Cancer	Signature	Type	HR	Low CI95	Up CI95	p-value	Number_Event	N/A_number	Likelihood_ratio_test	Wald_test	Score_test	zph	concordance
ACC	AR	(continuous)	0.164365951143155	0.0242416665388393	1.11445167566799	0.0644577423091917	46/14	46(50%)	0.0389312820463329	0.0644577423091917	0.0633042510702213	0.920412953247845	0.627737226277372
ACC	AR	H (vs L)	0.511895049214617	0.171057643131097	1.5318610534673	0.231161756559358	23/9--23/5	46(50%)	0.220456685484448	0.231161756559358	0.222651973747053	0.871050088998197	0.579075425790754
ACC	weiss_score_overall	(continuous)	1.26473725613742	1.04365622415868	1.5326505893753	0.0165816583804103	69/28	23(25%)	0.0141536207292585	0.0165816583804103	0.0143348991168115	0.0169780750805596	0.585803432137285
ACC	mitoses_per_50_hpf	(continuous)	1.02175862510958	1.010521253787	1.03312096017119	0.000136246788888683	61/24	31(33.7%)	0.00082044254989011	0.000136246788888683	2.07058962327089e-05	0.17170477931705	0.703214695752009
ACC	age_at_initial_pathologic_diagnosis	(continuous)	1.01351691180864	0.992817267844707	1.03464813092151	0.202214049175244	92/34	0(0%)	0.20045713129045	0.202214049175244	0.200811782194355	0.804475395847534	0.561792452830189
ACC	gender	MALE (vs FEMALE)	0.848598439813268	0.413528965025436	1.74139993315636	0.65443727432665	32/11--60/23	0(0%)	0.651459796896023	0.65443727432665	0.654075375788134	0.884256975321048	0.517688679245283
ACC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	8.00991843864135	3.53921423668734	18.1279767493642	5.94873209691649e-07	37/24--53/9	2(2.17%)	5.49369900681995e-08	5.94873209691649e-07	1.04686000979015e-08	0.325161744523809	0.745208845208845
ACC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	33.7767196682664	7.75632062233016	147.088658024804	2.74661615895511e-06	45/30--45/2	2(2.17%)	1.32338584535319e-12	2.74661615895511e-06	9.3665075695526e-12	0.706156852417986	0.770770010131712
ACC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	13.1636623792888	4.90062610769963	35.3591568562335	3.17783052428133e-07	25/17--54/7	13(14.13%)	1.99286006585808e-08	3.17783052428133e-07	2.55209298138936e-10	0.919980167841732	0.769461077844311
ACC	residual_tumor	R1 (vs R0)	7.62729348229386	2.52840407932728	23.0088245548635	0.000310327183685177	7/5--64/14	NA	NA	NA	NA	0.431020622126212	NA
ACC	residual_tumor	R2 (vs R0)	12.4669507308948	5.30195988948915	29.3146051207742	7.30458182829352e-09	12/11--64/14	NA	NA	NA	NA	0.580271256181809	NA
ACC	residual_tumor	RX (vs R0)	3.37981820127276	0.967345886667707	11.8087761896677	0.0563975303020207	6/3--64/14	NA	NA	NA	NA	0.0862491775670821	NA
ACC	residual_tumor	Global	NA	NA	NA	NA	NA	3(3.26%)	2.63012604806434e-07	1.08256514752547e-07	3.8040348648849e-11	0.196696787916019	0.752113376429637
ACC	new_tumor_event	Yes (vs No)	4.05476466102074	1.88282619642583	8.7321477083083	0.000347983916873629	44/25--48/9	0(0%)	0.000116023553529465	0.000347983916873629	0.000112194964227319	0.833865841032282	0.665094339622642
ACC	number_of_lymphnodes_positive_by_he	Yes (vs No)	2.36419785887111	0.911274481413968	6.13364209125879	0.0769020967701215	8/5--84/29	0(0%)	0.109642611096811	0.0769020967701215	0.0682079097462117	0.428407634339018	0.555188679245283
ACC	clinical_status_within_3_mths_surgery	Disease (vs No_evidence)	9.0028432656274	4.41030438768871	18.3776854703511	1.5821420840112e-09	20/18--72/16	0(0%)	6.98912128171969e-09	1.5821420840112e-09	7.72604202836646e-13	0.893623762048233	0.721933962264151
ACC	ct_scan_preop_results.1	Involvement (vs Normal)	3.50849746955336	1.66060897534973	7.41267491419517	0.00100572892201856	24/15--53/13	15(16.3%)	0.00120424975537625	0.00100572892201856	0.000462278364565138	0.280655222353607	0.667232021709634
ACC	history_adrenal_hormone_excess	None (vs Yes)	0.499472934188484	0.23304420022384	1.07049740670325	0.0742911007859723	38/9--54/25	0(0%)	0.0614105088852346	0.0742911007859723	0.06864552986855	0.266580359969194	0.56061320754717
ACC	invasion_of_tumor_capsule	Absent (vs Present)	0.380816285878527	0.174014855350984	0.833383122939772	0.01568821306685	35/9--48/22	9(9.78%)	0.0111116124792585	0.01568821306685	0.0122426824061231	0.0975886796961598	0.639905548996458
ACC	Mitotic_Rate_._5.50_HPF	Absent (vs Present)	0.391217204074474	0.174305577162628	0.878060835776076	0.0228925222775437	32/8--48/24	12(13.04%)	0.0153838116891827	0.0228925222775437	0.0185625793916105	0.203439306732267	0.585653753026634
ACC	necrosis	Absent (vs Present)	0.381967806811558	0.133993239358026	1.08885646872521	0.0717518900169519	20/4--67/29	5(5.43%)	0.0430251154672644	0.0717518900169519	0.0614588313982799	0.174615224519016	0.555960437272254
ACC	sinusoid_invasion	Present (vs Absent)	2.12886578290453	0.97169160399954	4.66410279039917	0.0589989293926944	29/15--39/11	24(26.09%)	0.0570394271743302	0.0589989293926944	0.053431760969318	0.124430096568299	0.562874251497006
ACC	weiss_venous_invasion	Present (vs Absent)	3.18683478766862	1.50684051294036	6.73987451006162	0.00242246228855592	36/19--43/12	13(14.13%)	0.00199735377138399	0.00242246228855592	0.00148974417737358	0.850561532622063	0.642156862745098
BLCA	AR	(continuous)	0.952413774320399	0.739516357914518	1.22660166716702	0.705653114871801	343/155	69(16.75%)	0.704627576825394	0.705653114871801	0.705649306985844	0.0254101638350339	0.53693574852804
BLCA	AR	H (vs L)	0.857714090858667	0.625033052496474	1.17701529338188	0.341821640003295	171/83--172/72	69(16.75%)	0.341194784355333	0.341821640003295	0.341354975876316	0.000829384521142007	0.54941925935459
BLCA	BMI	(continuous)	0.993441147538726	0.966874427774967	1.02073783861906	0.634208182326432	361/153	51(12.38%)	0.630507769995155	0.634208182326432	0.634276435382503	0.629734344249669	0.510043455799678
BLCA	tobacco_smoking_history	(continuous)	1.0453367996629	0.922455887955021	1.18458675260009	0.487105539242261	398/175	14(3.4%)	0.487526614648717	0.487105539242261	0.486985578146241	0.304785893000725	0.525047167529389
BLCA	age_at_initial_pathologic_diagnosis	(continuous)	1.03146925923741	1.0160026388791	1.04717132814296	5.8318737247598e-05	411/180	1(0.24%)	3.90086909038967e-05	5.8318737247598e-05	5.3369207405618e-05	0.050673675688531	0.60105294278177
BLCA	race	ASIAN (vs WHITE)	0.621738497166837	0.316476793222761	1.22144424847982	0.16778155672727	44/9--327/152	NA	NA	NA	NA	0.0325688499007987	NA
BLCA	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	1.25437146949369	0.711495125314883	2.21146670932342	0.433401379609602	23/13--327/152	NA	NA	NA	NA	0.657729903857642	NA
BLCA	race	Global	NA	NA	NA	NA	NA	19(4.61%)	0.229005381987568	0.2623728880636	0.255944768495011	0.0974323904693397	0.530146840700089
BLCA	gender	FEMALE (vs MALE)	1.11771312769827	0.808016181760891	1.54611091216825	0.501429957014188	108/51--304/130	1(0.24%)	0.504924324568667	0.501429957014188	0.50121003181337	0.563747306266809	0.514941326298554
BLCA	pathologic_stage_v2	StageI/II (vs StageIII/IV)	0.447355988626598	0.309042517707048	0.647572321261595	2.02151061819977e-05	133/35--277/145	3(0.73%)	4.43057266674707e-06	2.02151061819977e-05	1.19970307245199e-05	0.348162189752653	0.584225060407318
BLCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.78113450409233	4.05156794806129	8.24903261721167	0	165/124--222/43	26(6.31%)	0	0	0	0.0395489930409856	0.681734197309184
BLCA	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	4.65180146934711	2.68895797853318	8.04745075340453	3.86093295112744e-08	23/17--234/57	NA	NA	NA	NA	0.818772500278605	NA
BLCA	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	3.559724240905	2.08785906138958	6.0692011762772	3.09883223803542e-06	30/18--234/57	NA	NA	NA	NA	0.539551691652185	NA
BLCA	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	6.3956908116907	4.3301587445278	9.44650378243938	0	68/54--234/57	NA	NA	NA	NA	0.817262024204952	NA
BLCA	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	57(13.83%)	0	0	0	0.879131625009648	0.702924124023191
BLCA	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	5.12522731231144	3.63470644335697	7.22698116401456	0	121/89--234/57	57(13.83%)	0	0	0	0.79182916561957	0.692777917822032
BLCA	new_tumor_event	Yes (vs No)	1.83217510533573	1.36678232007082	2.45603529348993	5.1265940747891e-05	144/93--268/88	1(0.24%)	5.60173314068102e-05	5.1265940747891e-05	3.93880733692287e-05	0.000112299396981319	0.543527699445101
BLCA	pharmaceutical_tx_adjuvant	YES (vs NO)	0.665612035216521	0.453796838362941	0.976294552917846	0.0372770422613473	77/32--335/149	1(0.24%)	0.0298560211639222	0.0372770422613473	0.0359971058676678	0.171049664363276	0.541253524970436
BLCA	number_of_lymphnodes_positive_by_he	Yes (vs None)	2.03250846230108	1.51181803608946	2.73253166102659	2.63873916761526e-06	120/78--292/103	1(0.24%)	4.74248872261995e-06	2.63873916761526e-06	1.62435382788928e-06	0.465538789054263	0.574570181024288
BLCA	histologic_subtype	Papillary (vs Non-Papillary)	0.675275153857793	0.475653554125236	0.958673659563586	0.0280908828992149	133/42--274/135	6(1.46%)	0.023281991609588	0.0280908828992149	0.0271040399562615	0.466344800437618	0.545559129434414
BLCA	lymphovascular_invasion	YES (vs NO)	1.79529869567343	1.33727216560506	2.41020301594958	9.86353009686525e-05	153/82--259/99	1(0.24%)	0.000127476083647715	9.86353009686525e-05	7.85249890208339e-05	0.631439168920591	0.573501319021195
BLCA	extracapsular_extension	YES (vs NO)	1.41921864118918	0.997817973499829	2.01858615999286	0.0514375754647564	73/41--339/140	1(0.24%)	0.0595205606264705	0.0514375754647562	0.0502624536247733	0.161262336521353	0.518398071500045
BRCA	AR	(continuous)	1.07206633920914	0.871226426265393	1.31920497475265	0.510868155220792	873/121	224(20.42%)	0.50951954933676	0.510868155220792	0.510773968780059	0.0076761399136791	0.47587484273799
BRCA	AR	H (vs L)	1.08177593844958	0.754148899928516	1.5517349174936	0.669353943330978	437/62--436/59	224(20.42%)	0.669423409443608	0.669353943330978	0.669275699661649	0.0419382480659078	0.475898140813569
BRCA	age_at_initial_pathologic_diagnosis	(continuous)	1.03268283282516	1.02007561574284	1.0454458637708	2.87362519002521e-07	1096/151	1(0.09%)	3.13899995330047e-07	2.87362519002521e-07	2.24256760494868e-07	0.700603546692185	0.635736137373365
BRCA	gender	MALE (vs FEMALE)	0.84182749945734	0.117528357572452	6.02980891999385	0.863909965915033	12/1--1085/150	1(0.09%)	0.860008258973578	0.863909965915033	0.86374344581538	0.671390280575146	0.498039939122815
BRCA	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.5738657666488	0.910408832475383	2.7208143891728	0.104399094031222	621/65--183/16	NA	NA	NA	NA	0.305105005690264	NA
BRCA	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	3.01584387696609	1.70046552397406	5.34872019573659	0.00015936600508315	249/44--183/16	NA	NA	NA	NA	0.00253503952500933	NA
BRCA	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	13.007444821841	6.41634865902463	26.3691438518178	1.11510800593351e-12	20/15--183/16	NA	NA	NA	NA	0.0374983556157882	NA
BRCA	ajcc_pathologic_tumor_stage	Stage_X (vs Stage_I)	4.18772714420872	1.71045718203138	10.2528486644227	0.00171914720285971	13/7--183/16	NA	NA	NA	NA	0.0290265228122628	NA
BRCA	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	12(1.09%)	5.27037302688882e-11	1.65423230669148e-14	0	0.00300809803514079	0.69372226735829
BRCA	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.64856178262154	1.89289287630443	3.70590412388196	1.32217542470059e-08	269/59--804/81	NA	NA	NA	NA	0.000348274032020202	NA
BRCA	pathologic_stage_v2	Stage_X (vs StageI/II)	2.97072401138018	1.36070707451491	6.48574650421139	0.00627383220989308	13/7--804/81	NA	NA	NA	NA	0.0575661067846515	NA
BRCA	pathologic_stage_v2	Global	NA	NA	NA	NA	NA	12(1.09%)	6.90958159577093e-08	2.06303503169636e-08	4.67350613764239e-09	0.000727298649571551	0.663075745265921
BRCA	histological_type	Infiltrating_Lobular_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	0.846999026729723	0.538995164977484	1.33100888077738	0.47148639663677	203/23--784/106	NA	NA	NA	NA	0.930106601706134	NA
BRCA	histological_type	Other_specify (vs Infiltrating_Ductal_Carcinoma)	1.27685649493289	0.661626936376094	2.46417190566973	0.466250003752209	46/10--784/106	NA	NA	NA	NA	0.354456178257939	NA
BRCA	histological_type	Mixed_Histology_(please_specify) (vs Infiltrating_Ductal_Carcinoma)	1.02135517955947	0.448171526303997	2.32760526179739	0.959900604197361	30/6--784/106	NA	NA	NA	NA	0.503591710515245	NA
BRCA	histological_type	Mucinous_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	4.07965081933304	1.28149783046067	12.9875762658933	0.0173233942960406	17/3--784/106	NA	NA	NA	NA	0.731335089672911	NA
BRCA	histological_type	Metaplastic_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	2.35796364725126	0.327483883407292	16.9779120239743	0.394408645726573	9/1--784/106	NA	NA	NA	NA	0.855862379394064	NA
BRCA	histological_type	Medullary_Carcinoma (vs Infiltrating_Ductal_Carcinoma)	1.06538654983856	0.261399885134283	4.34219204034396	0.929596142956796	6/2--784/106	NA	NA	NA	NA	0.0287988371938712	NA
BRCA	histological_type	Infiltrating_Carcinoma_NOS (vs Infiltrating_Ductal_Carcinoma)	1.01566519374425e-05	0	Inf	0.995891408485394	1/0--784/106	NA	NA	NA	NA	0.999638639967036	NA
BRCA	histological_type	Global	NA	NA	NA	NA	NA	2(0.18%)	0.576343614221657	0.361870655315042	0.266622357669576	0.488465838139695	0.52166556428912
BRCA	menopause_status	Pre (vs Post)	0.456905363068991	0.275127303974222	0.758785143406799	0.00247355110848213	229/18--705/91	NA	NA	NA	NA	0.297532290455807	NA
BRCA	menopause_status	Peri (vs Post)	0.178340651764923	0.0248406233688026	1.28037801627321	0.0864884538684553	39/1--705/91	NA	NA	NA	NA	0.453827055003787	NA
BRCA	menopause_status	Indeterminate (vs Post)	0.666856653844513	0.362137678540668	1.2279799179382	0.193363790609462	34/15--705/91	NA	NA	NA	NA	0.0901904659466284	NA
BRCA	menopause_status	Global	NA	NA	NA	NA	NA	91(8.3%)	0.00150357856308636	0.00593932342418702	0.00359003280638426	0.171846257341968	0.585485987348466
BRCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	10.9315878412962	7.6539834434648	15.6127346779157	0	126/83--935/49	37(3.37%)	0	0	0	0.00555488614016253	0.78428833872802
BRCA	margin_status	Positive (vs Negative)	1.9809907213779	1.20361901712171	3.26043721672814	0.00716693569300386	79/19--920/89	NA	NA	NA	NA	0.0728333814535504	NA
BRCA	margin_status	Close (vs Negative)	1.90443099962542	0.830123675568748	4.36905673103394	0.128383007725696	31/6--920/89	NA	NA	NA	NA	0.830465037139784	NA
BRCA	margin_status	Global	NA	NA	NA	NA	NA	68(6.2%)	0.0213860245179001	0.0125628018821393	0.010630557316845	0.200055842402914	0.534975921620724
BRCA	new_tumor_event_type	Distant_Metastasis (vs No)	5.3464713441837	3.7500438609121	7.62251240102161	0	64/46--995/95	NA	NA	NA	NA	0.0963013917283085	NA
BRCA	new_tumor_event_type	New_Primary_Tumor (vs No)	0.678508677970649	0.246841165993753	1.86506178670833	0.452169252698851	19/4--995/95	NA	NA	NA	NA	0.143607824137472	NA
BRCA	new_tumor_event_type	Locoregional_Disease (vs No)	1.93970306413824	0.780583565902731	4.820045080857	0.153700227921664	10/5--995/95	NA	NA	NA	NA	0.683106537645298	NA
BRCA	new_tumor_event_type	Locoregional_Recurrence (vs No)	0.785079322088458	0.109331685138413	5.63742835565536	0.809890699390525	9/1--995/95	NA	NA	NA	NA	0.663967275620175	NA
BRCA	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.09%)	2.09832151654155e-14	0	0	0.345091237315328	0.632776829774478
BRCA	new_tumor_event_dx_days_to	Yes (vs No)	3.14129467034475	2.25081384139693	4.38407300703824	1.69509961622794e-11	113/60--984/91	1(0.09%)	2.05193306790363e-10	1.69509961622794e-11	1.65623070813581e-12	0.0124238878379573	0.626058817199342
BRCA	number_of_lymphnodes_positive_by_he	Yes (vs None)	1.60419280970631	1.16222247119455	2.21423577197611	0.00405038905955013	473/86--624/65	1(0.09%)	0.0038214054004192	0.00405038905955013	0.00372021542172474	0.341239188074857	0.564927977370905
BRCA	surgical_procedure_first	Other (vs Modified_Radical_Mastectomy)	0.707100473871885	0.470526108407647	1.06262133219751	0.0953755531459509	272/39--322/58	NA	NA	NA	NA	0.141182079983712	NA
BRCA	surgical_procedure_first	Lumpectomy (vs Modified_Radical_Mastectomy)	0.563738594647789	0.34862606268883	0.911581884166593	0.0194130822892037	247/24--322/58	NA	NA	NA	NA	0.270853814205601	NA
BRCA	surgical_procedure_first	Simple_Mastectomy (vs Modified_Radical_Mastectomy)	0.538779289569857	0.314963387072116	0.921640847108793	0.0239535698643681	200/18--322/58	NA	NA	NA	NA	0.929807903663165	NA
BRCA	surgical_procedure_first	Global	NA	NA	NA	NA	NA	57(5.2%)	0.0372241180785454	0.0361555761377048	0.0332949750304957	0.380797046936217	0.572100802468066
BRCA	micromet_detection_by_ihc	YES (vs NO)	0.40901264541023	0.24094799660513	0.694304773073646	0.000928623636202053	263/18--467/66	367(33.45%)	0.000393748512252823	0.000928623636202053	0.000630665706795819	0.969553268484755	0.603892076290898
BRCA	er_status_by_ihc	Negative (vs Positive)	1.36109381005523	0.944332842499752	1.96178325733826	0.098355744594714	238/41--808/100	52(4.74%)	0.106114787189348	0.098355744594714	0.0970692213283642	0.0120151085112482	0.561508720680471
BRCA	pr_status_by_ihc	Negative (vs Positive)	1.33454990811029	0.952378539621438	1.87007936775341	0.0936373538124619	344/56--699/86	55(5.01%)	0.0975172942662099	0.0936373538124619	0.092518285996355	0.000921223577338592	0.579602709879485
BRCA	her2_status_by_ihc	Positive (vs Negative)	1.64313103707711	1.00859729144845	2.67686580947368	0.0461146007801888	164/23--564/57	369(33.64%)	0.0546136803700116	0.0461146007801888	0.0439602802343548	0.306722136043986	0.5610433772912
CESC	AR	(continuous)	0.617750839002949	0.299601495718895	1.27374564059889	0.192026382305459	171/30	136(44.3%)	0.166994943171568	0.192026382305459	0.192834814779255	0.772592279769977	0.571561771561772
CESC	AR	H (vs L)	0.916420919686425	0.446834367725902	1.87950471740366	0.811759962226495	86/15--85/15	136(44.3%)	0.8117905539458	0.811759962226495	0.811702576889675	0.970610827673762	0.512354312354312
CESC	BMI	(continuous)	0.952253851978423	0.910819291172097	0.995573334245958	0.0311288296760479	262/52	45(14.66%)	0.0242743428927059	0.0311288296760479	0.0313397480385302	0.753645290817198	0.598963372494817
CESC	age_at_initial_pathologic_diagnosis	(continuous)	1.01686061887883	0.999272520890233	1.03475828326136	0.0603518513170338	307/71	0(0%)	0.0629687221714951	0.0603518513170338	0.0596971116788939	0.819235627384363	0.559015952679692
CESC	BMI_category	Over (vs Normal)	0.480094337688715	0.23114354971943	0.997175016826311	0.049119876813473	75/10--99/26	NA	NA	NA	NA	0.239438102077882	NA
CESC	BMI_category	Obesity (vs Normal)	0.645043368273296	0.345771064088598	1.20334229832125	0.168162133108866	88/16--99/26	NA	NA	NA	NA	0.874157850879166	NA
CESC	BMI_category	Global	NA	NA	NA	NA	NA	45(14.66%)	0.100774287062877	0.106343320107582	0.0987819263189247	0.425218678905141	0.56558396682792
CESC	clinical_stage	Stage_II (vs Stage_I)	0.8076049964134	0.410257196507538	1.58979741436395	0.536336965062315	70/11--163/36	NA	NA	NA	NA	0.342514745459558	NA
CESC	clinical_stage	Stage_III (vs Stage_I)	1.24105206623818	0.615433886272067	2.50264125110778	0.546189787768132	46/10--163/36	NA	NA	NA	NA	0.377753780268337	NA
CESC	clinical_stage	Stage_IV (vs Stage_I)	4.44756321075941	2.39303807381462	8.26598570668329	2.36700148270597e-06	21/14--163/36	NA	NA	NA	NA	0.08969012094891	NA
CESC	clinical_stage	Global	NA	NA	NA	NA	NA	7(2.28%)	0.000229696045991101	9.89695383923905e-06	7.85414437376453e-07	0.345599971938846	0.615844203229043
CESC	clinical_stage_v2	StageIII/IV (vs StageI/II)	2.25977753818685	1.38068311851567	3.69859995650831	0.00118189264641155	67/24--233/47	7(2.28%)	0.00210740124061759	0.00118189264641155	0.000858929342444803	0.114816272752725	0.604168566998084
CESC	histological_grade	G2 (vs G1)	1.88373933327869	0.452234028923794	7.84654326916912	0.384363208059097	136/37--18/2	NA	NA	NA	NA	0.65706004357498	NA
CESC	histological_grade	G3 (vs G1)	1.60260351879068	0.375909215502104	6.8323359271991	0.523809007484892	120/22--18/2	NA	NA	NA	NA	0.72566600292645	NA
CESC	histological_grade	G4 (vs G1)	5.23503262222373e-07	0	Inf	0.99569580097868	1/0--18/2	NA	NA	NA	NA	0.999996510077568	NA
CESC	histological_grade	GX (vs G1)	3.80620393939681	0.821988747622004	17.6245580857292	0.0873985399835897	24/9--18/2	NA	NA	NA	NA	0.918068405260657	NA
CESC	histological_grade	Global	NA	NA	NA	NA	NA	8(2.61%)	0.190699720670991	0.219869301165697	0.159032813329647	0.967716367616972	0.568287565003193
CESC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	0.873063462785214	0.517060719435352	1.47417852758744	0.611527591460084	121/22--154/39	NA	NA	NA	NA	0.806380263732491	NA
CESC	histological_grade_v2	GX (vs G_1/2/Low)	2.12084664131664	1.01878688865856	4.41504550761013	0.0444610101053052	24/9--154/39	NA	NA	NA	NA	0.537576494354468	NA
CESC	histological_grade_v2	Global	NA	NA	NA	NA	NA	8(2.61%)	0.11322721586096	0.0747657513232041	0.0649759554856633	0.823833512927482	0.55679226347961
CESC	histological_type	Adenocarcinoma (vs Cervical_Squamous_Cell_Carcinoma)	0.947380322204577	0.483945659085492	1.85460796692856	0.874677151859406	47/10--254/60	NA	NA	NA	NA	0.695952207657474	NA
CESC	histological_type	Adenosquamous (vs Cervical_Squamous_Cell_Carcinoma)	1.60538198758778	0.219323778118989	11.7508979107275	0.641155348972427	6/1--254/60	NA	NA	NA	NA	0.742227502828479	NA
CESC	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.895908698412926	0.882448871344796	0.880495584152181	0.883100031265062	0.510082452052339
CESC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	21.7232746364354	11.3569200925791	41.5518166090073	0	80/53--200/14	27(8.79%)	0	0	0	0.782444730151069	0.812434392594713
CESC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	13.6149781103795	7.30596330365838	25.3720996454076	2.22044604925031e-16	36/26--183/22	88(28.66%)	1.4432899320127e-15	2.22044604925031e-16	0	0.457046417953787	0.770143312101911
CESC	new_tumor_event_type	Distant_Metastasis (vs No)	3.91042600854504	2.27363676844275	6.7255384767457	8.27528989444382e-07	31/20--260/40	NA	NA	NA	NA	0.178907659789807	NA
CESC	new_tumor_event_type	Locoregional_Recurrence (vs No)	4.58460074281038	2.12494656630731	9.89133764784642	0.000103959196277703	13/8--260/40	NA	NA	NA	NA	0.349026878141391	NA
CESC	new_tumor_event_type	New_Primary_Tumor (vs No)	50.5840937558374	13.5420886937691	188.947997532809	5.36384303639892e-09	3/3--260/40	NA	NA	NA	NA	0.639963886605061	NA
CESC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	3.81697939921821e-09	3.59501317603872e-12	0	0.523906637994647	0.641647248610862
CESC	new_tumor_event_dx_days_to	Yes (vs No)	4.46366731653708	2.77689037818558	7.17504949753901	6.5153693551423e-10	48/32--259/39	0(0%)	5.53606083197877e-09	6.5153693551423e-10	1.42290623728059e-11	0.176672204513207	0.633984585051084
CESC	number_of_lymphnodes_positive_by_he	Yes (vs No)	1.27348669770268	0.737278878943815	2.19966747392647	0.385960762670207	52/17--255/54	0(0%)	0.396107880643111	0.385960762670207	0.384819020728941	0.143040187899233	0.502106112206489
CESC	performance_status_scale_timing	Pre-Adjuvant_Therapy (vs Preoperative)	1.8771501144419	0.933366233301035	3.77525179980744	0.0773069110805977	52/18--96/14	NA	NA	NA	NA	0.496299494577268	NA
CESC	performance_status_scale_timing	Post-Adjuvant_Therapy (vs Preoperative)	0.479206679442933	0.0626767453904287	3.66386353012181	0.478449918650261	15/1--96/14	NA	NA	NA	NA	0.0673581146843308	NA
CESC	performance_status_scale_timing	Other (vs Preoperative)	4.62467005760035	1.31802536059072	16.2269814991114	0.0167971835877114	9/3--96/14	NA	NA	NA	NA	0.0534957641808795	NA
CESC	performance_status_scale_timing	Global	NA	NA	NA	NA	NA	135(43.97%)	0.0495814323820675	0.0409204523216077	0.024395661341307	0.0427612056739968	0.651416765053129
CESC	lymphovascular_involvement	ABSENT (vs PRESENT)	0.10022199817077	0.0235689891862286	0.426172240055624	0.00184025691389289	72/2--80/23	155(50.49%)	2.6307497535405e-05	0.00184025691389289	0.000124817352966877	0.36297286631629	0.720306513409962
CESC	corpus_involvement	PRESENT (vs ABSENT)	3.21124621220743	1.23518605615751	8.34862260953308	0.0166994264888187	19/7--99/11	189(61.56%)	0.0245816519360392	0.0166994264888187	0.0114782979994177	0.100027489279961	0.591002044989775
CHOL	AR	(continuous)	0.956098922490494	0.291389213311049	3.13712762116449	0.940967856251441	30/15	15(33.33%)	0.940804929995988	0.940967856251441	0.940965882023184	0.135000153277257	0.592452830188679
CHOL	AR	H (vs L)	0.798664529978234	0.289319841152782	2.20470545298176	0.664330821831983	15/8--15/7	15(33.33%)	0.663874879524046	0.664330821831983	0.663670951717019	0.379950796801243	0.549056603773585
CHOL	BMI	(continuous)	0.962383013145635	0.878511012972218	1.0542623260439	0.409847561107812	41/20	4(8.89%)	0.395694158138065	0.409847561107812	0.407721027510892	0.270295124808236	0.598326359832636
CHOL	age_at_initial_pathologic_diagnosis	(continuous)	1.00272177058273	0.969475064843038	1.03710862265792	0.874461769058574	45/22	0(0%)	0.873713968619498	0.874461769058574	0.874450919147928	0.249194170941212	0.53428093645485
CHOL	BMI_category	Over (vs Normal)	0.544793427858731	0.197210203921298	1.50499250615101	0.241406776678479	20/9--12/7	NA	NA	NA	NA	0.0997421386857129	NA
CHOL	BMI_category	Obesity (vs Normal)	0.532726316532202	0.154683823949	1.83469299556195	0.318228004371844	9/4--12/7	NA	NA	NA	NA	0.454269129823635	NA
CHOL	BMI_category	Global	NA	NA	NA	NA	NA	4(8.89%)	0.461454853219698	0.436601911927143	0.426213209762344	0.257937190096432	0.597280334728033
CHOL	gender	MALE (vs FEMALE)	1.41367607898265	0.608426639064519	3.28466889510376	0.420920006447362	20/10--25/12	0(0%)	0.424419289986058	0.420920006447362	0.41866211450635	0.267932399623652	0.566889632107023
CHOL	pathologic_stage_v2	StageIII/IV (vs StageI/II)	0.759894528377506	0.294363101019346	1.96165787171851	0.57040254881393	14/6--31/16	0(0%)	0.563290436736511	0.57040254881393	0.569202830800914	0.874083479219144	0.533444816053512
CHOL	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	0.717440596541837	0.306346436506839	1.68019258012429	0.444382863723574	22/11--23/11	0(0%)	0.445243657966984	0.444382863723574	0.442498929332222	0.528566377827439	0.555183946488294
CHOL	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.0540608292824808	0.00719423678813933	0.406238124873481	0.00457710981709014	19/1--22/18	4(8.89%)	1.48487145417153e-05	0.00457710981709014	8.49578767317949e-05	0.0800464434058064	0.710084033613445
CHOL	new_tumor_event_type	Yes (vs No)	2.95601180684852	1.15372358224391	7.57374291096056	0.023955058990521	21/16--24/6	0(0%)	0.0163120799599278	0.023955058990521	0.0178817640302465	0.0867584779691022	0.596153846153846
CHOL	new_tumor_event_after_initial_treatment	YES (vs NO)	2.67353234533569	1.08822671927533	6.56827761619011	0.0320067751858676	19/15--26/7	0(0%)	0.0254194550971848	0.0320067751858676	0.0256971671764061	0.0472713236817329	0.581939799331104
CHOL	perineural_invasion_present	YES (vs NO)	2.30287502226931	0.800508282782916	6.62483259980211	0.121804639586621	9/5--36/17	0(0%)	0.146019972808248	0.121804639586621	0.111618269102097	0.834493096314734	0.57190635451505
CHOL	Smoking	Yes (vs No)	1.42452712051528	0.5862507226676	3.46144992000997	0.434733285718244	14/8--31/14	0(0%)	0.441835572451493	0.434733285718244	0.432399643348395	0.323380911523154	0.52257525083612
CHOL	vascular_invasion	Micro (vs None)	1.42597828847332	0.472836702496239	4.30045736395321	0.528650002211786	7/4--38/18	0(0%)	0.543026506228855	0.528650002211786	0.526517727461306	0.592307238950553	0.520903010033445
COAD	AR	(continuous)	1.06534220197863	0.447379881172755	2.53689102947929	0.886303817513434	351/76	108(23.53%)	0.886258020630866	0.886303817513434	0.886310163580709	0.325110592453364	0.4822921181351
COAD	AR	H (vs L)	1.41430172580485	0.891729996963678	2.24311100717189	0.140747899359926	175/30--176/46	108(23.53%)	0.13694015979882	0.140747899359926	0.138798581031168	0.0540001388176928	0.51003033867872
COAD	BMI	(continuous)	0.949362832096855	0.900469757283976	1.00091066876633	0.0540766032440829	233/47	226(49.24%)	0.0366377805733512	0.0540766032440829	0.240405951128774	0.406750682374504	0.570586253369272
COAD	cea_level_pretreatment	(continuous)	1.00106255910004	1.00049455847154	1.00163088219377	0.0002450176801575	287/52	172(37.47%)	0.00836613316366752	0.0002450176801575	2.85316380643774e-06	0.830323175212749	0.709681200187529
COAD	age_at_initial_pathologic_diagnosis	(continuous)	1.02103265463016	1.0045661434115	1.03776907937665	0.0121021735337006	458/102	1(0.22%)	0.0101462261084451	0.0121021735337006	0.0117019207510407	0.65360857480396	0.570507742167807
COAD	gender	FEMALE (vs MALE)	0.889995180551362	0.601566896324458	1.31671377903985	0.559782884901713	216/46--243/56	1(0.22%)	0.559138079422173	0.559782884901713	0.55956602478537	0.0453786647971826	0.493428159884768
COAD	BMI_category	Over (vs Normal)	0.792855262005617	0.431099344088562	1.45817773817085	0.455274054000989	81/19--78/23	NA	NA	NA	NA	0.493020830567872	NA
COAD	BMI_category	Obesity (vs Normal)	0.272978671811121	0.103612072450498	0.719195683489151	0.00861772705678421	74/5--78/23	NA	NA	NA	NA	0.643890402784454	NA
COAD	BMI_category	Global	NA	NA	NA	NA	NA	226(49.24%)	0.0109378257432456	0.0317394816595327	0.0209463078768461	0.760539620518974	0.60427897574124
COAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.93644393077456	0.746996127572473	5.01985881669758	0.173902164786288	178/29--76/5	NA	NA	NA	NA	0.206289910144777	NA
COAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	3.41890032988884	1.33046480901468	8.78556079538144	0.0106824356215548	129/32--76/5	NA	NA	NA	NA	0.978723169167409	NA
COAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	9.10003791880251	3.53388328419029	23.4333404541451	4.74444007170227e-06	65/31--76/5	NA	NA	NA	NA	0.799104578831849	NA
COAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	12(2.61%)	2.72578226656606e-09	9.16513531734608e-10	8.76165806573681e-12	0.0830833619476291	0.696714666254874
COAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.89691843838132	1.90623291664308	4.40247168400199	6.32019252266858e-07	194/63--254/34	12(2.61%)	2.81181962824562e-07	6.32019252266858e-07	1.84562397032018e-07	0.00881358164171131	0.656719298922905
COAD	histological_type	Colon_Mucinous_Adenocarcinoma (vs Colon_Adenocarcinoma)	1.42663377002953	0.845761382762136	2.40645169579833	0.182864775276546	62/17--392/82	6(1.31%)	0.200327292859932	0.182864775276546	0.180575606368759	0.66770273622351	0.519250995417324
COAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	8.33215621633544	5.12133951513485	13.5559899921201	0	145/64--285/22	30(6.54%)	0	0	0	0.0802748454560824	0.764529191883232
COAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	8.89217975175347	4.61381138000803	17.1378615693121	6.68431976436068e-11	41/20--197/17	221(48.15%)	6.06599215302595e-10	6.68431976436068e-11	4.77395900588817e-15	0.237715956915825	0.757913998170174
COAD	residual_tumor	R1 (vs R0)	1.45885572124014	0.345883739624867	6.1531080290254	0.607066293339875	4/2--331/50	NA	NA	NA	NA	0.562875445890367	NA
COAD	residual_tumor	R2 (vs R0)	5.82949371585267	3.07267276340915	11.0597514280894	6.82756273739926e-08	26/12--331/50	NA	NA	NA	NA	0.850105451855632	NA
COAD	residual_tumor	RX (vs R0)	1.22980619479967	0.48795462354523	3.09951623324959	0.660955900758475	25/5--331/50	NA	NA	NA	NA	0.645281296727815	NA
COAD	residual_tumor	Global	NA	NA	NA	NA	NA	74(16.12%)	0.000136096422830523	2.02889023370734e-06	4.13794968290304e-08	0.899898779551787	0.587058388310007
COAD	new_tumor_event_dx_days_to	Yes (vs No)	2.04133347071667	1.36881106668918	3.0442786737159	0.000466026776530737	88/40--371/62	1(0.22%)	0.000716659017852783	0.000466026776530737	0.000353869299333343	0.000990052472967129	0.539377025567159
COAD	number_of_lymphnodes_positive_by_he	Yes (vs No)	2.37125522596843	1.59777761991734	3.5191701752422	1.81642462691034e-05	182/60--277/42	1(0.22%)	1.49281602811469e-05	1.81642462691034e-05	9.88309841942758e-06	0.0149183530802475	0.632319049333813
COAD	perineural_invasion_present	YES (vs NO)	1.48918706050415	0.830629015959546	2.66987795822558	0.181237511676007	46/13--413/89	1(0.22%)	0.202981042493952	0.181237511676007	0.17838034687438	0.292489305587146	0.517446885127836
COAD	vascular_invasion_indicator	YES (vs NO)	2.39579276383675	1.58838183195834	3.61362919907981	3.09234381562495e-05	96/35--363/67	1(0.22%)	8.08825798817026e-05	3.09234381562495e-05	1.71714195550399e-05	0.301461800403736	0.609038530788621
COAD	lymphovascular_invasion_indicator	YES (vs NO)	2.08916000238201	1.40770009019201	3.10051092982276	0.000254615765748034	164/48--295/54	1(0.22%)	0.000318037266623605	0.000254615765748034	0.000186986299825165	0.593338369957451	0.603060857039971
COAD	mismatch_rep_proteins_tested_by_ihc	YES (vs NO)	0.161704698320103	0.0392021567911804	0.667014562440564	0.0117335774682048	56/2--287/53	117(25.49%)	0.000700259330889685	0.0117335774682048	0.00407190991846773	0.651910663598662	0.568187433089023
DLBC	AR	(continuous)	0.155011057056849	0.0299204223245521	0.803077829224499	0.026333067774247	33/6	15(31.25%)	0.0314230341271136	0.0263330677742472	0.0163198985309828	0.435239244100219	0.764227642276423
DLBC	AR	H (vs L)	0.197015485749498	0.0219676727547933	1.76691914789386	0.146673936936003	17/4--16/2	15(31.25%)	0.10010253224949	0.146673936936003	0.106333979164186	0.935230266306331	0.682926829268293
DLBC	BMI	(continuous)	0.963663613414706	0.845099464716943	1.09886184832756	0.580566497132732	48/9	0(0%)	0.565354818199171	0.580566497132732	0.57982356341297	0.890633726908248	0.572314049586777
DLBC	age_at_initial_pathologic_diagnosis	(continuous)	0.989346494565471	0.941192401324191	1.03996428884453	0.673962075183864	48/9	0(0%)	0.675924346641082	0.673962075183864	0.673542049120839	0.606949027903242	0.506198347107438
DLBC	gender	MALE (vs FEMALE)	1.03913662668493	0.249712116274595	4.32419918195209	0.95791404326541	22/5--26/4	0(0%)	0.957923038641263	0.95791404326541	0.957911768285183	0.854802277697915	0.516528925619835
DLBC	clinical_stage_v2	StageIII/IV (vs StageI/II)	1.91666005779097	0.421513072480882	8.71523569959481	0.399816769771733	17/4--25/3	6(12.5%)	0.396858819046857	0.399816769771733	0.39210365227203	0.348815679417237	0.538674033149171
DLBC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.2515183843707	1.38763352826837	28.164123534039	0.0170080304382082	9/4--37/5	2(4.17%)	0.0194558787950482	0.0170080304382082	0.00640222314329686	0.524975145896622	0.672916666666667
DLBC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	6.39379375545399	1.40425800605273	29.1118857154996	0.0164420918640954	11/4--35/5	2(4.17%)	0.0187959712332902	0.0164420918640954	0.00620209873160538	0.707918750379547	0.725206611570248
DLBC	new_tumor_event_dx_days_to	Yes (vs No)	2.83057697396616	0.697301608782392	11.4902445435886	0.145506599698799	12/5--36/4	0(0%)	0.153885451013192	0.145506599698799	0.128975868668088	0.96675556169295	0.634297520661157
ESCA	AR	(continuous)	1.36860353874034	0.513045836717503	3.65089337482324	0.530780570668801	126/44	59(31.89%)	0.538642267003453	0.530780570668801	0.530843645269286	0.0546968547906151	0.571103896103896
ESCA	AR	H (vs L)	1.35438382971677	0.745369466427203	2.46100174587367	0.319481695160261	63/22--63/22	59(31.89%)	0.320318472310367	0.319481695160261	0.317739145699307	0.152694559813509	0.558766233766234
ESCA	BMI	(continuous)	1.0143206320726	0.980766248613273	1.04902299207672	0.407421868987449	175/70	10(5.41%)	0.422506980737767	0.407421868987449	0.40781862513564	0.680542042064879	0.548126758477714
ESCA	tobacco_smoking_history	(continuous)	1.1422587936407	0.914695845650506	1.42643607473871	0.240645528660844	166/61	19(10.27%)	0.241388445720602	0.240645528660844	0.239366189259192	0.322830636306441	0.526659696811291
ESCA	age_at_initial_pathologic_diagnosis	(continuous)	1.00147737187364	0.983148317350808	1.0201481390697	0.875525496124492	185/77	0(0%)	0.875584442352589	0.875525496124492	0.87552272115417	0.0479106434374421	0.550850785340314
ESCA	tobacco_smoking_history_v2	No (vs Yes)	1.75686242565781	1.01031336756681	3.05505765020391	0.0458999578850233	19/16--166/61	0(0%)	0.0590828535423784	0.0458999578850233	0.0431176127412495	0.0332227775895375	0.510274869109948
ESCA	gender	FEMALE (vs MALE)	0.440333784641398	0.190895018190959	1.01570928217026	0.0544282979317945	27/6--158/71	0(0%)	0.0309326572134887	0.0544282979317944	0.0480243189950547	0.376073612853589	0.528992146596859
ESCA	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.09173760306788	0.714922016596621	6.12006078777241	0.177879538320106	79/25--18/4	NA	NA	NA	NA	0.464429382195252	NA
ESCA	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	5.24745136430155	1.7458382242004	15.772220724129	0.0031533584950022	56/27--18/4	NA	NA	NA	NA	0.509226803237811	NA
ESCA	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	11.0926056269268	3.15833624713181	38.959087939503	0.000173858168871943	9/8--18/4	NA	NA	NA	NA	0.361624682649185	NA
ESCA	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	23(12.43%)	2.3869130199361e-05	2.26090451723726e-05	3.08779865354492e-06	0.834607863199032	0.644438346139773
ESCA	pathologic_stage_v2	StageIII/IV (vs StageI/II)	3.17740695661482	1.88442166326918	5.35756681465305	1.44434427047369e-05	65/35--97/29	23(12.43%)	1.29179692047732e-05	1.44434427047369e-05	5.20216792687656e-06	0.838838917509063	0.629345042078302
ESCA	histological_grade	G2 (vs G1)	2.17593734850679	0.758625721796724	6.24115846403562	0.148141693223534	77/30--19/4	NA	NA	NA	NA	0.0493547174145422	NA
ESCA	histological_grade	G3 (vs G1)	2.94637419611594	1.02443489091874	8.47405821540533	0.044989549812204	49/26--19/4	NA	NA	NA	NA	0.290104332008122	NA
ESCA	histological_grade	GX (vs G1)	2.88229112016115	0.958366598325121	8.66850129781078	0.0595284442256708	40/17--19/4	NA	NA	NA	NA	0.35129346142097	NA
ESCA	histological_grade	Global	NA	NA	NA	NA	NA	0(0%)	0.113291788891005	0.176541952737872	0.154942735037774	0.0859457740362963	0.583573298429319
ESCA	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.54679349554272	0.926969879070456	2.58106565474651	0.0949833141402748	49/26--96/34	NA	NA	NA	NA	0.231520290379041	NA
ESCA	histological_grade_v2	GX (vs G_1/2/Low)	1.50044709185282	0.836288832033022	2.69206210727047	0.173667147705895	40/17--96/34	NA	NA	NA	NA	0.189383954608525	NA
ESCA	histological_grade_v2	Global	NA	NA	NA	NA	NA	0(0%)	0.179048615539844	0.181678014434069	0.177100999807076	0.317191514904729	0.580039267015707
ESCA	histological_type	Esophagus_Adenocarcinoma_NOS (vs Esophagus_Squamous_Cell_Carcinoma)	1.13978184488708	0.715455701830806	1.81576951670087	0.581854449189279	89/45--96/32	0(0%)	0.580858406590235	0.581854449189279	0.581614643002185	0.34224359395951	0.530628272251309
ESCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	2.91143992311553	1.7735106894312	4.77949328212369	2.38439080773034e-05	78/51--100/24	7(3.78%)	9.64265740832637e-06	2.38439080773034e-05	9.7638910603326e-06	0.0151945448258948	0.591815960912052
ESCA	new_tumor_event_type	Distant_Metastasis (vs NO)	1.77567786037519	1.05954658025763	2.97583128724738	0.0292929763116144	36/23--114/42	NA	NA	NA	NA	0.131928713452551	NA
ESCA	new_tumor_event_type	Locoregional_Recurrence (vs NO)	0.858508411712788	0.450310637094808	1.63672947576061	0.64308121813032	33/12--114/42	NA	NA	NA	NA	0.000495731909940456	NA
ESCA	new_tumor_event_type	New_Primary_Tumor (vs NO)	1.16257371326388e-07	0	Inf	0.995350113621898	2/0--114/42	NA	NA	NA	NA	0.999895717706681	NA
ESCA	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	0.0426845954817076	0.109261060891756	0.0539418123592925	0.0061089761434735	0.595418848167539
ESCA	new_tumor_event_dx_days_to	Yes (vs NO)	1.24409533171225	0.789843444351719	1.95959491144297	0.346085619376701	71/35--114/42	0(0%)	0.347808893367661	0.346085619376701	0.345157950489716	0.00646327145808212	0.483769633507853
ESCA	number_of_lymphnodes_positive_by_he	Yes (vs NO)	1.93669459462752	1.21411246637333	3.08932331784996	0.00553245856238904	90/47--95/30	0(0%)	0.00474660282457584	0.00553245856238904	0.00475860224533331	0.175088698519073	0.556675392670157
ESCA	alcohol_history_documented	NO (vs YES)	1.29166647247345	0.80777240711752	2.06543608250447	0.28524001568786	53/27--129/50	3(1.62%)	0.291867657818072	0.28524001568786	0.283946755951319	0.10509569174625	0.503094140882159
ESCA	esoph_non_ca_degree_of_dysplasia	Low_grade_dysplasia (vs Negative/no_dysplasia)	3.45742626557257	1.24863447612535	9.57349537469526	0.01697352055609	6/5--42/18	NA	NA	NA	NA	0.526010276113392	NA
ESCA	esoph_non_ca_degree_of_dysplasia	High_grade_dysplasia (vs Negative/no_dysplasia)	1.10795023991245	0.573107586543848	2.14192546555679	0.760521927205319	30/18--42/18	NA	NA	NA	NA	0.605424322326797	NA
ESCA	esoph_non_ca_degree_of_dysplasia	Global	NA	NA	NA	NA	NA	107(57.84%)	0.101975479353885	0.0528367606466487	0.0368424855145663	0.771120640989963	0.551925320886814
GBM	AR	(continuous)	0.760864964327028	0.484602963401068	1.19461814652843	0.235078650550589	209/159	387(64.93%)	0.234053960498132	0.235078650550589	0.235097131355579	0.724249086754309	0.538112127434509
GBM	AR	H (vs L)	0.742520381463608	0.542451707391161	1.01637898706307	0.0630923560051896	105/83--104/76	387(64.93%)	0.0628998371771152	0.0630923560051891	0.0621529031839559	0.855470822317935	0.540818866280879
GBM	karnofsky_performance_score	(continuous)	0.974452839332295	0.9672704971495	0.981688513069585	7.06845693088098e-12	439/359	157(26.34%)	1.0139056261238e-10	7.06845693088098e-12	1.76026970777343e-11	0.0239004704940378	0.602189733593242
GBM	age_at_initial_pathologic_diagnosis	(continuous)	1.03409706492093	1.02685785264953	1.04138731268296	0	596/491	0(0%)	0	0	0	1.88550259220266e-05	0.653538255557725
GBM	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	0.746548635046147	0.523244037391055	1.06515282480464	0.106985645111177	51/33--507/431	NA	NA	NA	NA	0.0444112279760208	NA
GBM	race	ASIAN (vs WHITE)	0.442731917884595	0.209608788091967	0.93513040601986	0.0326982265049317	13/7--507/431	NA	NA	NA	NA	0.745178411149892	NA
GBM	race	Global	NA	NA	NA	NA	NA	25(4.19%)	0.0147557889090927	0.0314144698268295	0.0276036275119725	0.122522353020695	0.511003912333346
GBM	gender	FEMALE (vs MALE)	0.828435982228182	0.688858659086139	0.996294620961646	0.0455651993277603	230/184--366/307	0(0%)	0.0440030551924815	0.0455651993277603	0.0452569583914029	0.0900308564645662	0.511122423363365
GBM	histological_type	Glioblastoma_Multiforme_(GBM) (vs Untreated_primary_(de_novo)_GBM)	0.980034942229869	0.638460049512001	1.50435174248667	0.926508895847243	31/22--545/450	NA	NA	NA	NA	0.20764525512595	NA
GBM	histological_type	Treated_primary_GBM (vs Untreated_primary_(de_novo)_GBM)	0.527195389061323	0.33200649261931	0.837137177814803	0.00665896417917444	20/19--545/450	NA	NA	NA	NA	0.0294032379675796	NA
GBM	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.0113309073343577	0.0251849565553937	0.022250729211687	0.0375697887114599	0.514445203760007
GBM	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.278784173788228	0.13205361897779	0.588553469086347	0.000807038738451227	27/7--514/445	55(9.23%)	2.78693282478315e-05	0.000807038738451227	0.000340370583796545	0.105636561599108	0.514425863068135
GBM	new_tumor_event_type	Progression_of_Disease (vs No)	0.692630694489609	0.565708750335335	0.848028740345247	0.000376429508169629	256/227--230/166	NA	NA	NA	NA	2.36610731008113e-12	NA
GBM	new_tumor_event_type	Recurrence (vs No)	0.563964927919365	0.437288774942742	0.727337306942627	1.02067167361275e-05	107/95--230/166	NA	NA	NA	NA	1.88414839286111e-11	NA
GBM	new_tumor_event_type	Locoregional_Disease (vs No)	0.539003385138521	0.171858385518847	1.69048864455278	0.2892683397217	3/3--230/166	NA	NA	NA	NA	0.0443579003908298	NA
GBM	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	6.10931995805863e-05	4.75332275924334e-05	3.92772009657483e-05	3.75255382323303e-14	0.612054057069538
GBM	new_tumor_event_dx_days_to	No (vs Yes)	1.85618561534334	1.53136748919992	2.2499008650155	2.93676749585359e-10	215/160--381/331	0(0%)	1.40843325890927e-09	2.93676749585359e-10	1.59467439253547e-10	8.10462807976364e-15	0.610847675099718
GBM	history_of_neoadjuvant_treatment	Yes (vs No)	0.473496664926289	0.300817475302762	0.745299426074466	0.00123763059451243	21/20--575/471	0(0%)	0.000304129532753605	0.00123763059451243	0.000960761865133164	0.06699253476928	0.518761680287858
HNSC	AR	(continuous)	1.01328210179115	0.635456009686854	1.61575404458958	0.955800943521747	345/171	183(34.66%)	0.955870938795749	0.955800943521747	0.955800970577646	0.301982830303546	0.534513857077416
HNSC	AR	H (vs L)	1.13668626947415	0.839982083550946	1.53819432641827	0.406469888679841	172/85--173/86	183(34.66%)	0.406650135985156	0.406469888679841	0.406159229857761	0.203866979084326	0.525194686211635
HNSC	tobacco_smoking_history	(continuous)	0.966142403434219	0.857764038673867	1.08821435922724	0.570450538447914	514/214	14(2.65%)	0.570094194250717	0.570450538447914	0.570383455496865	0.820659754039644	0.506960660370343
HNSC	age_at_initial_pathologic_diagnosis	(continuous)	1.0204828938657	1.00814271814248	1.03297411956839	0.00108909971179927	527/223	1(0.19%)	0.00100364474365766	0.00108909971179927	0.00109172312707151	0.984555161735936	0.556422267765277
HNSC	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	1.60074495962117	1.03589268175748	2.4736002781729	0.0341095159911623	48/23--452/189	NA	NA	NA	NA	0.886325191013022	NA
HNSC	race	ASIAN (vs WHITE)	1.133893060905	0.420509248726579	3.05751532805047	0.803915654120265	11/4--452/189	NA	NA	NA	NA	0.796505363391746	NA
HNSC	race	AMERICAN_INDIAN_OR_ALASKA_NATIVE (vs WHITE)	0.653679877968452	0.0913436722185443	4.67790896164674	0.672000547366525	2/1--452/189	NA	NA	NA	NA	0.1020971658922	NA
HNSC	race	Global	NA	NA	NA	NA	NA	15(2.84%)	0.234441600459528	0.192260972175031	0.185095180379271	0.427570779852485	0.526216730879943
HNSC	tobacco_smoking_history_v2	No (vs Yes)	1.89876223592349	0.961165082976136	3.75096650141075	0.0649016845244988	13/9--515/214	1(0.19%)	0.091342792040181	0.0649016845244988	0.0607060442831503	0.0763130069345247	0.512387246085853
HNSC	gender	FEMALE (vs MALE)	1.37646013094301	1.03831580523252	1.82472662221623	0.0263258371143507	142/72--386/151	1(0.19%)	0.0294772036176643	0.0263258371143507	0.0257036453837847	0.899758511898015	0.534470980244538
HNSC	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.07243880466075	0.722246672182411	5.94672535642909	0.175432200924276	74/26--27/4	NA	NA	NA	NA	0.724960897532042	NA
HNSC	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.25321465048847	0.789432219092164	6.43117437873806	0.128986746725333	82/29--27/4	NA	NA	NA	NA	0.951008979463782	NA
HNSC	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	3.74569843433143	1.38513902258664	10.1291325507186	0.00927212583182058	270/133--27/4	NA	NA	NA	NA	0.739052447467248	NA
HNSC	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	76(14.39%)	0.000206191357148389	0.0008272169618182	0.000499453772145331	0.781124817605477	0.574237199190344
HNSC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.84705485106745	1.24937125973772	2.7306628003977	0.00209706515066221	352/162--101/30	76(14.39%)	0.00100535795088053	0.00209706515066221	0.00178562922847136	0.685190727786559	0.54919784091761
HNSC	histological_grade	G2 (vs G1)	1.69107777419797	1.07833908980376	2.65198958790114	0.0221082232136157	311/136--63/23	NA	NA	NA	NA	0.619286353334203	NA
HNSC	histological_grade	G3 (vs G1)	1.40373212390832	0.860544909880947	2.28978621925121	0.17434086787492	125/56--63/23	NA	NA	NA	NA	0.175814554104272	NA
HNSC	histological_grade	G4 (vs G1)	1.60277177872075e-07	0	Inf	0.992071369262947	7/0--63/23	NA	NA	NA	NA	0.999994660908682	NA
HNSC	histological_grade	GX (vs G1)	0.933323183127167	0.379355524310999	2.29624220115086	0.880586541903213	18/7--63/23	NA	NA	NA	NA	0.82621807485725	NA
HNSC	histological_grade	Global	NA	NA	NA	NA	NA	5(0.95%)	0.00457213389725108	0.136692138877931	0.0267054690391432	0.561825730855715	0.548673565912268
HNSC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	0.860866737603592	0.632967140146189	1.17082150542774	0.339659341873388	132/56--374/159	NA	NA	NA	NA	0.244870862007099	NA
HNSC	histological_grade_v2	GX (vs G_1/2/Low)	0.615135663114465	0.271376102617618	1.39434489767305	0.244509963419489	18/7--374/159	NA	NA	NA	NA	0.520259359329422	NA
HNSC	histological_grade_v2	Global	NA	NA	NA	NA	NA	5(0.95%)	0.32260357893161	0.354071135550515	0.349982067935772	0.382454811424715	0.515269169408011
HNSC	laterality	Left (vs Right)	1.44962068905423	0.990940188137517	2.12061249234796	0.0557388283832418	146/56--168/52	NA	NA	NA	NA	0.967773350718809	NA
HNSC	laterality	Midline (vs Right)	1.82945445561959	0.989415159247286	3.38270904170559	0.054100354279277	34/13--168/52	NA	NA	NA	NA	0.936512624702113	NA
HNSC	laterality	Global	NA	NA	NA	NA	NA	181(34.28%)	0.0636363919597376	0.0621980566306003	0.0592479688142157	0.996717296719193	0.557881147059974
HNSC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	7.04930995408687	5.20908893172071	9.53962803863539	0	163/130--335/67	31(5.87%)	0	0	0	0.839210667428158	0.717827811517635
HNSC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	5.21472550040185	3.56174579718415	7.63484077556569	0	55/38--386/121	88(16.67%)	1.32893696047631e-13	0	0	0.789237746145786	0.61039333907551
HNSC	margin_status	Positive (vs Negative)	1.73776796784113	1.21488893994354	2.48569018184907	0.00247982134603919	60/38--357/148	NA	NA	NA	NA	0.477879322438554	NA
HNSC	margin_status	Close (vs Negative)	1.36897722904602	0.854455834144766	2.19332419389741	0.191577707832432	50/20--357/148	NA	NA	NA	NA	0.708773720403158	NA
HNSC	margin_status	Global	NA	NA	NA	NA	NA	62(11.74%)	0.011101907273216	0.0072903713259761	0.00652316636872941	0.75103694676444	0.538712605159353
HNSC	new_tumor_event_after_initial_treatment	YES (vs NO)	2.1336844279063	1.45454392864229	3.12992213452044	0.000105915554477254	49/31--150/36	1(0.19%)	0.000386720772956095	0.000105915554477254	7.20779955691864e-05	0.359766735588082	0.534735873520432
HNSC	new_tumor_event_type	Locoregional_Recurrence (vs No)	1.81572296700452	1.11727729792809	2.95078929735839	0.0160593410911682	29/18--458/188	NA	NA	NA	NA	0.365863971046583	NA
HNSC	new_tumor_event_type	Distant_Metastasis (vs No)	1.80578585459451	1.00397055447622	3.2479663254216	0.0484734101156435	20/12--458/188	NA	NA	NA	NA	0.18529312934237	NA
HNSC	new_tumor_event_type	Locoregional_Disease (vs No)	0.602393234637557	0.192369219073851	1.88636004701869	0.384157790530524	11/3--458/188	NA	NA	NA	NA	0.80429119931607	NA
HNSC	new_tumor_event_type	New_Primary_Tumor (vs No)	0.386586673993409	0.095917008880144	1.55811006050069	0.181424050772065	10/2--458/188	NA	NA	NA	NA	0.0152976998940949	NA
HNSC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.19%)	0.0187666181860399	0.0166281021657821	0.0129877395826465	0.089660263940101	0.538214340485452
HNSC	new_tumor_event_dx_days_to	Yes (vs No)	2.21173942423491	1.69052320561056	2.89365520951144	7.07503311492275e-09	145/93--383/130	1(0.19%)	2.01591477955176e-08	7.07503311492275e-09	2.86476498079224e-09	0.00386149284055293	0.567338659082354
HNSC	postoperative_rx_tx	YES (vs NO)	1.43816499008305	0.961530615450484	2.15106883282294	0.0768962280528458	66/28--462/195	1(0.19%)	0.090002350744748	0.0768962280528458	0.075304051791573	0.256493020978195	0.515043149720468
HNSC	number_of_lymphnodes_positive_by_he	Yes (vs No)	1.40918856263644	1.08231359970414	1.83478467387659	0.0108525408114244	241/118--287/105	1(0.19%)	0.0108060108518461	0.0108525408114244	0.0104730250164932	0.518003492979972	0.54759713915262
HNSC	perineural_invasion_present	YES (vs NO)	1.58331847525784	1.21262009486907	2.06733947812691	0.000734120692471918	172/94--356/129	1(0.19%)	0.000887021355719608	0.000734120692471918	0.000659199617780271	0.153155971367558	0.566495183124904
HNSC	extracapsular_spread_pathologic	Microscopic_Extension (vs No_Extranodal_Extension)	2.73461904109639	1.90060822351534	3.93460430582348	5.97698913695766e-08	77/47--248/82	NA	NA	NA	NA	0.877455059533482	NA
HNSC	extracapsular_spread_pathologic	Gross_Extension (vs No_Extranodal_Extension)	2.5888048247539	1.62061929346339	4.13540086046154	6.88370476167321e-05	38/24--248/82	NA	NA	NA	NA	0.192029331069463	NA
HNSC	extracapsular_spread_pathologic	Global	NA	NA	NA	NA	NA	166(31.44%)	4.43004114503154e-08	1.58525325089087e-08	3.80502473973365e-09	0.368441162525843	0.616202993370582
HNSC	lymphovascular_invasion	YES (vs NO)	1.65264475666709	1.18277521777995	2.30917477022025	0.00324521890323604	124/63--232/78	173(32.77%)	0.00371755532376927	0.00324521890323604	0.0029394565138956	0.996812573224457	0.558703950839515
KICH	AR	(continuous)	0.381894564608505	0.0147504794601938	9.88737070351499	0.562031028453278	62/8	51(45.13%)	0.551884836449617	0.562031028453278	0.562201689866219	0.33929718620372	0.502604166666667
KICH	AR	H (vs L)	0.879504692184074	0.219843418189486	3.51854292452407	0.855967879553396	31/4--31/4	51(45.13%)	0.856016730799423	0.855967879553396	0.855870234875727	0.347671633035773	0.5
KICH	age_at_initial_pathologic_diagnosis	(continuous)	1.06843338539522	1.01832996165325	1.12100197579751	0.00690914703472201	112/12	1(0.88%)	0.00433706164163883	0.00690914703472201	0.00480082957301375	0.786473304140245	0.70398773006135
KICH	gender	FEMALE (vs MALE)	0.835517141080639	0.265031198444753	2.63398761027406	0.759031802584362	51/5--62/8	1(0.88%)	0.758017804832825	0.759031802584362	0.758718425211731	0.387813006282347	0.507668711656442
KICH	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.31294332040698	0.184602992479575	9.33798601770783	0.785611290213181	33/2--54/3	NA	NA	NA	NA	0.0734534170501772	NA
KICH	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	4.62081501822318	0.84404978747718	25.2970046902762	0.0776466977711553	19/4--54/3	NA	NA	NA	NA	0.064752919977574	NA
KICH	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	23.6450752541409	4.28870072780117	130.36339424426	0.000281728767776546	7/4--54/3	NA	NA	NA	NA	0.0573317400340041	NA
KICH	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	1(0.88%)	0.00158401298558342	0.000446555371119595	6.31264737704917e-07	0.199646329069857	0.73721881390593
KICH	pathologic_stage_v2	StageIII/IV (vs StageI/II)	6.81654065825765	2.05119030828556	22.652811081443	0.00173352945146399	26/8--87/5	1(0.88%)	0.00119048885084838	0.00173352945146399	0.000279095190218959	0.337602778179918	0.711145194274029
KICH	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	25.6444481113494	6.88945394020454	95.4557102266028	1.31147010640209e-06	16/10--96/3	2(1.77%)	1.57861000160686e-07	1.31147010640209e-06	7.21755988308814e-13	0.0973235247852546	0.803480040941658
KIRC	AR	(continuous)	0.289685011176346	0.195972485822701	0.428210140561063	5.1851212212739e-10	445/157	92(17.13%)	4.01292443719115e-10	5.1851212212739e-10	4.86148010736542e-10	0.178369147385462	0.648508623450295
KIRC	AR	H (vs L)	0.457363126006773	0.32847990560217	0.636815298175445	3.61966720940909e-06	223/104--222/53	92(17.13%)	1.78413470608429e-06	3.61966720940909e-06	2.02789695891159e-06	0.783691204435177	0.597053845098129
KIRC	age_at_initial_pathologic_diagnosis	(continuous)	1.02810529558008	1.0154895900432	1.04087772948499	1.08257841265891e-05	537/177	0(0%)	9.94015472077781e-06	1.08257841265891e-05	9.54021180721298e-06	0.390013130456036	0.592342226121059
KIRC	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	0.880529757901488	0.477290443641128	1.62444621483564	0.683860397126576	56/11--466/163	NA	NA	NA	NA	0.265923254283066	NA
KIRC	race	ASIAN (vs WHITE)	0.529233790170542	0.073944606705606	3.7878138398029	0.526283185624173	8/1--466/163	NA	NA	NA	NA	0.2826708013753	NA
KIRC	race	Global	NA	NA	NA	NA	NA	7(1.3%)	0.720519751700069	0.757230410550288	0.752183738265393	0.310387770601454	0.512943650863202
KIRC	tobacco_smoking_history_v2	Yes (vs No)	0.36748373967923	0.207779298468426	0.64994106691121	0.00057954564040108	87/13--450/164	0(0%)	7.71469533976665e-05	0.00057954564040108	0.000345755192142527	0.320126237938798	0.549254347489551
KIRC	gender	FEMALE (vs MALE)	1.04064639738236	0.766464423268417	1.4129095774164	0.79845113508601	191/65--346/112	0(0%)	0.798803406251295	0.79845113508601	0.798438138482462	0.919643567552054	0.505719249359272
KIRC	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.19987696580914	0.647138502400486	2.2247242711397	0.562960764701425	57/13--269/45	NA	NA	NA	NA	0.821838970765504	NA
KIRC	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.70563524552531	1.81169188518322	4.04067719334544	1.15047725279815e-06	125/51--269/45	NA	NA	NA	NA	0.000592006584841598	NA
KIRC	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	6.57434931584594	4.50229306773172	9.60001232184103	0	83/67--269/45	NA	NA	NA	NA	4.79866345433066e-05	NA
KIRC	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	3(0.56%)	0	0	0	0.000100160189373533	0.730388238156477
KIRC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	3.90817616299473	2.85297568235479	5.35365268462207	0	208/118--326/58	3(0.56%)	0	0	0	3.53651359541463e-06	0.698185673073581
KIRC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	2.67675423189142	1.90708953455396	3.75704081435507	1.25450548837946e-08	285/131--244/45	NA	NA	NA	NA	0.0256249238834375	NA
KIRC	histological_grade_v2	GX (vs G_1/2/Low)	0.944073155497587	0.129895573030607	6.86146650064172	0.954649151903513	5/1--244/45	NA	NA	NA	NA	0.0434470796314766	NA
KIRC	histological_grade_v2	Global	NA	NA	NA	NA	NA	3(0.56%)	7.33938931851696e-09	6.74668485523e-08	1.70859366654952e-08	0.017949052481656	0.625267499654839
KIRC	laterality	Left (vs Right)	1.44432488449722	1.07361038877272	1.94304600047936	0.0151281980035546	253/98--283/79	NA	NA	NA	NA	0.537201610982342	NA
KIRC	laterality	Bilateral (vs Right)	2.67644669411657e-06	0	Inf	0.993620184927825	1/0--283/79	NA	NA	NA	NA	0.999540133252235	NA
KIRC	laterality	Global	NA	NA	NA	NA	NA	0(0%)	0.0429218651685144	0.0522993551791261	0.0462078550075407	0.826648564904539	0.542055833634347
KIRC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.02958566678794	3.63721063563472	6.95498130675188	0	159/110--353/55	25(4.66%)	0	0	0	0.171538017832223	0.7021415038371
KIRC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	6.24178080672754	1.96322447698472	19.8448155552084	0.0019154449886668	19/6--120/6	398(74.12%)	0.00324348092197302	0.0019154449886668	0.000414888079547593	0.0771418202373555	0.748720573183214
KIRC	new_tumor_event_dx_days_to	Yes (vs NO)	2.31929573408745	1.72246929167144	3.12291936243257	2.98603853865487e-08	127/78--410/99	0(0%)	7.44621464487949e-08	2.98603853865487e-08	1.16493712454258e-08	0.52713326220913	0.598061475480331
KIRC	history_of_neoadjuvant_treatment	Yes (vs No)	2.00755796875644	1.05973068589428	3.80312569180388	0.0325219562862501	18/10--519/167	0(0%)	0.0528310709196708	0.0325219562862501	0.029150571587187	0.345833949472845	0.511292292343946
KIRC	lymph_nodes_examined_positive	Yes (vs NO)	3.2163856578565	1.78739859460946	5.78781740752424	9.7208192693099e-05	18/12--519/165	0(0%)	0.000876730723105457	9.7208192693099e-05	3.74786240664449e-05	0.350233819783819	0.527977019798063
KIRC	serum_calcium_level	Low (vs Normal)	0.789860715694055	0.558358081064307	1.1173474000905	0.182537823702429	204/66--151/62	NA	NA	NA	NA	0.26167395660639	NA
KIRC	serum_calcium_level	Elevated (vs Normal)	3.83657735424821	1.89585953030971	7.76393269638794	0.000185090346747074	10/9--151/62	NA	NA	NA	NA	0.514206012904921	NA
KIRC	serum_calcium_level	Global	NA	NA	NA	NA	NA	172(32.03%)	0.000919824097090127	5.51925205373172e-05	9.16954155416594e-06	0.496176002985722	0.563076973085424
KIRC	hemoglobin_level	Low (vs Normal)	2.23939243435224	1.57647113043876	3.18107853560143	6.74441250614333e-06	263/118--186/43	NA	NA	NA	NA	0.11556310065392	NA
KIRC	hemoglobin_level	Elevated (vs Normal)	5.8876749157217	1.81964004596075	19.0503149181442	0.0030845170380579	5/3--186/43	NA	NA	NA	NA	0.830184270261324	NA
KIRC	hemoglobin_level	Global	NA	NA	NA	NA	NA	83(15.46%)	2.73121181892932e-06	5.27716364895348e-06	2.03136483667432e-06	0.287137185834321	0.582309310306653
KIRC	platelet_count	Low (vs Normal)	1.63716348608392	1.01489007244102	2.64097989816747	0.0433269006882426	46/20--360/108	NA	NA	NA	NA	0.741182680030494	NA
KIRC	platelet_count	Elevated (vs Normal)	3.81562835512497	2.54084286982042	5.7299961037979	1.0833500763141e-10	38/30--360/108	NA	NA	NA	NA	0.373744496668615	NA
KIRC	platelet_count	Global	NA	NA	NA	NA	NA	93(17.32%)	5.33524069368241e-08	6.4085226014754e-10	3.26710880571568e-11	0.592113048284365	0.593997562461913
KIRC	white_cell_count	Low (vs Normal)	2.03237122097791	0.891899188880895	4.63116553008866	0.0914655794421387	9/6--268/104	NA	NA	NA	NA	0.574139450615754	NA
KIRC	white_cell_count	Elevated (vs Normal)	0.760290615792034	0.536802864280844	1.076823278944	0.122785289112771	164/46--268/104	NA	NA	NA	NA	0.0915376119054878	NA
KIRC	white_cell_count	Global	NA	NA	NA	NA	NA	96(17.88%)	0.0674366553778032	0.0494304638730056	0.0437820143736064	0.176356202886851	0.554950175639831
KIRP	AR	(continuous)	0.424692908344035	0.208234279258696	0.866159342447374	0.0185173229376221	206/30	85(29.21%)	0.0135482802207517	0.0185173229376221	0.0173719758287342	0.673828706311161	0.656985187336625
KIRP	AR	H (vs L)	0.545623616809002	0.259539546873618	1.14705113269194	0.110027859648035	103/19--103/11	85(29.21%)	0.103124625660768	0.110027859648035	0.104690731938106	0.63076110823119	0.591199535288992
KIRP	BMI	(continuous)	1.00395588492245	0.997983778111858	1.00996372984877	0.194645263550799	212/30	79(27.15%)	0.285080333050478	0.194645263550799	0.16486338202267	0.406598585719817	0.415591256254938
KIRP	tobacco_smoking_history	(continuous)	0.742846236758585	0.558531407251741	0.987984783490743	0.0410482910643838	247/39	44(15.12%)	0.0316914596860935	0.0410482910643838	0.0381420530841269	0.232703367124696	0.568711542047362
KIRP	age_at_initial_pathologic_diagnosis	(continuous)	1.00543944274212	0.979776315500585	1.03177476024729	0.680915578795418	288/44	3(1.03%)	0.680165215338135	0.680915578795418	0.680886391945612	0.044804700897176	0.483152009670595
KIRP	BMI_category	Over (vs Normal)	0.799042599544867	0.341135217902776	1.87160117859594	0.605432293488963	86/13--51/9	NA	NA	NA	NA	0.600430283378522	NA
KIRP	BMI_category	Obesity (vs Normal)	0.699075907931446	0.268799042992228	1.81811333704899	0.462881515271818	76/8--51/9	NA	NA	NA	NA	0.857214263228278	NA
KIRP	BMI_category	Global	NA	NA	NA	NA	NA	79(27.15%)	0.758884038204168	0.754988579655186	0.753437699471521	0.754757879198308	0.537002897023966
KIRP	tobacco_smoking_history_v2	No (vs Yes)	0.593296555990772	0.23311489716833	1.50998845473327	0.273370253035324	43/5--248/39	1(0.34%)	0.242070748614053	0.273370253035324	0.268010388192833	0.032531247863486	0.556460044809559
KIRP	gender	FEMALE (vs MALE)	1.6343791421012	0.847625116371009	3.15138748079081	0.1425189703613	77/13--214/31	1(0.34%)	0.156440538299612	0.142518970361301	0.138623055195654	0.52115114201647	0.562658700522778
KIRP	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	0.975297096571296	0.217433381782418	4.37469361320174	0.973941947241645	21/2--173/12	NA	NA	NA	NA	0.36106181572309	NA
KIRP	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	4.59758517102077	2.17396823076652	9.72313629318174	6.54925783595273e-05	52/16--173/12	NA	NA	NA	NA	0.040491459546707	NA
KIRP	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	16.3475169081363	6.79436347772684	39.3327954764075	4.45034786800136e-10	15/9--173/12	NA	NA	NA	NA	3.55714537584317e-05	NA
KIRP	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	31(10.65%)	2.00411921502663e-08	1.79381820508695e-09	1.54321000422897e-14	9.00165874772041e-05	0.823720326409496
KIRP	pathologic_stage_v2	StageIII/IV (vs StageI/II)	6.20339240847884	3.22258174759654	11.9413812860678	4.70858456669276e-08	67/25--194/14	31(10.65%)	2.55978659380318e-08	4.70858456669276e-08	4.17552770137775e-10	0.000279109480267326	0.784959198813056
KIRP	clinical_stage	Stage_II (vs Stage_I)	0.564874882616963	0.0728506918818364	4.37996709117163	0.584689282122105	21/1--139/11	NA	NA	NA	NA	0.471179838083539	NA
KIRP	clinical_stage	Stage_III (vs Stage_I)	6.58859401678997	2.90420047367009	14.9471675635474	6.45713357461108e-06	29/12--139/11	NA	NA	NA	NA	0.0033688569712379	NA
KIRP	clinical_stage	Stage_IV (vs Stage_I)	19.6662443495355	7.47234584468268	51.759002441095	1.60489133094188e-09	11/7--139/11	NA	NA	NA	NA	0.00189233344904693	NA
KIRP	clinical_stage	Global	NA	NA	NA	NA	NA	91(31.27%)	1.00981062400862e-08	1.21732346425318e-09	3.33066907387547e-16	0.00173383560240581	0.849078341013825
KIRP	clinical_stage_v2	StageIII/IV (vs StageI/II)	9.22610979249042	4.46988821145381	19.0432283485234	1.85804316377158e-09	40/19--160/12	91(31.27%)	2.89112833673499e-09	1.85804316377158e-09	2.76223488526739e-13	9.99964097894157e-05	0.82344470046083
KIRP	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	15.2679420984224	7.74813592678697	30.085953334255	3.33066907387547e-15	47/28--229/12	16(5.5%)	2.22044604925031e-16	3.33066907387547e-15	0	0.00289262659177381	0.844822006472492
KIRP	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	7.09369159579039	3.05621122340892	16.4649812391106	5.10620957161478e-06	14/8--185/17	92(31.62%)	9.44315622359859e-05	5.10620957161478e-06	1.02460794182413e-07	0.935934658761295	0.640286448769739
KIRP	new_tumor_event_dx_days_to	Yes (vs No)	4.73775661703661	2.61284787779947	8.59075568577623	3.00621401660983e-07	53/24--238/20	1(0.34%)	5.64815713310907e-07	3.00621401660983e-07	1.62739788311939e-08	0.00804455782521529	0.72755787901419
KIRP	lymph_nodes_examined_positive	Yes (vs NO)	8.95009755150945	4.90903953590451	16.3177023928319	8.53206394424433e-13	29/19--262/25	1(0.34%)	2.07785011419048e-10	8.53206394424433e-13	0	0.000486724668392946	0.749439880507842
KIRP	hemoglobin_level	Low (vs Normal)	4.34003662545375	1.86006950840283	10.126459159289	0.000684751011439166	97/23--112/7	NA	NA	NA	NA	0.568548652035948	NA
KIRP	hemoglobin_level	Elevated (vs Normal)	1.64315891882175e-06	0	Inf	0.998078069896947	1/0--112/7	NA	NA	NA	NA	0.999840670430584	NA
KIRP	hemoglobin_level	Global	NA	NA	NA	NA	NA	81(27.84%)	0.000880900395611728	0.00313509044170579	0.00100626119565939	0.849966376051604	0.673252279635258
LAML	wbc_24hr_of_banking	(continuous)	1.00371743643491	0.999738940385637	1.00771176504824	0.0670831087144458	185/120	15(7.5%)	0.0813536821963365	0.0670831087144458	0.0666422187061196	0.485856918524221	0.560974655819775
LAML	metamyelocytes_24hr_of_banking	(continuous)	1.14521910306059	0.983592756283158	1.33340428306016	0.0806648696668808	186/120	14(7%)	0.103797424947819	0.0806648696668808	0.0783032003071409	0.245486500295848	0.527084624922505
LAML	basophils_count	(continuous)	0.971761720671158	0.868890942936692	1.08681169879633	0.615842382011303	186/120	14(7%)	0.603099201665762	0.615842382011303	0.615440419569596	0.658746076054797	0.486089584624923
LAML	basophils_count.1	(continuous)	1.11975593670185	0.991107431069714	1.26510337676082	0.0692915529543178	186/120	14(7%)	0.10403334418749	0.0692915529543178	0.0647216779609524	0.611769822713258	0.513484190948543
LAML	age_at_initial_pathologic_diagnosis	(continuous)	1.04354112515009	1.0291142204646	1.05817027714173	1.96885630021626e-09	186/120	14(7%)	1.89522397775477e-10	1.96885630021626e-09	9.74600400382997e-10	0.0785238234560049	0.691723496590205
LAML	gender	FEMALE (vs MALE)	1.0878069619547	0.759394456663273	1.5582468058518	0.646245514725104	91/63--109/70	14(7%)	0.646594542981894	0.646245514725104	0.646149329222952	0.529235728586978	0.503913515189089
LAML	history_neoadjuvant_hydroxyurea_tx	YES (vs NO)	1.49761504442353	0.990604023598217	2.26412448148239	0.0554673864007418	49/35--151/98	14(7%)	0.063743955242191	0.0554673864007419	0.0538412798481493	0.123578878955497	0.523984810911345
LAML	fab_category	M1 (vs M0_Undifferentiated)	1.04173392876275	0.523032811087003	2.07484034525505	0.907408152329126	44/31--19/14	NA	NA	NA	NA	0.774003763509429	NA
LAML	fab_category	M2 (vs M0_Undifferentiated)	1.04692934367866	0.527319071173737	2.07855378379498	0.895722765201824	44/29--19/14	NA	NA	NA	NA	0.876355867285109	NA
LAML	fab_category	M3 (vs M0_Undifferentiated)	0.29880192126144	0.111621453133623	0.799869430499594	0.0161967203434067	21/7--19/14	NA	NA	NA	NA	0.123229850837811	NA
LAML	fab_category	M4 (vs M0_Undifferentiated)	1.02525940140891	0.522709065115433	2.01097878404927	0.942143663691462	42/30--19/14	NA	NA	NA	NA	0.314530038133045	NA
LAML	fab_category	M5 (vs M0_Undifferentiated)	1.46619204543893	0.683745474480281	3.14403413893509	0.325512752561396	22/15--19/14	NA	NA	NA	NA	0.18134487829481	NA
LAML	fab_category	M6 (vs M0_Undifferentiated)	2.46473927058223	0.68545303565614	8.86266360485964	0.167109465713613	3/3--19/14	NA	NA	NA	NA	0.236545074323559	NA
LAML	fab_category	M7 (vs M0_Undifferentiated)	2.31251747137284	0.646243795487202	8.27510777317871	0.197467866334442	3/3--19/14	NA	NA	NA	NA	0.301048742542183	NA
LAML	fab_category	Global	NA	NA	NA	NA	NA	16(8%)	0.0105134114817745	0.0397039257963014	0.020163491469408	0.0476317035091587	0.58600078647267
LAML	cyto_risk_group	Poor (vs Intermediate/Normal)	1.4120018800282	0.916103677371819	2.17633588691946	0.118054273633214	43/34--116/82	NA	NA	NA	NA	0.662313633971576	NA
LAML	cyto_risk_group	Favorable (vs Intermediate/Normal)	0.369840073667997	0.204831572397138	0.667776351516503	0.000968988546463434	38/14--116/82	NA	NA	NA	NA	0.877111795754306	NA
LAML	cyto_risk_group	Global	NA	NA	NA	NA	NA	17(8.5%)	5.80789564627038e-05	0.000360547717289883	0.000170084922959779	0.906616448163088	0.599628762811718
LGG	AR	(continuous)	1.91122454927018	1.02691657488467	3.55703605051192	0.0409764180167027	426/97	89(17.28%)	0.0474710254010023	0.0409764180167028	0.0406717405675596	0.572253645104454	0.555233246507222
LGG	AR	H (vs L)	1.5657969160232	1.04040519453978	2.35650494162736	0.0315647264391408	213/40--213/57	89(17.28%)	0.0299973767577879	0.0315647264391408	0.03023591385225	0.908581881641109	0.560650011839924
LGG	eastern_cancer_oncology_group	(continuous)	1.89898017085816	1.3244449516168	2.72274486373357	0.000485892165911883	149/30	366(71.07%)	0.00347293712910623	0.000485892165911883	0.000437874260905025	0.395528936895271	0.713576158940397
LGG	karnofsky_performance_score	(continuous)	0.959643191142652	0.943815232510705	0.975736587612245	1.20600454911468e-06	295/87	220(42.72%)	7.38133479205594e-06	1.20600454911468e-06	8.2398460266031e-07	0.00540917742734626	0.695446850218302
LGG	age_at_initial_pathologic_diagnosis	(continuous)	1.05833693306885	1.04335931333733	1.07352955935656	6.32827124036339e-15	514/125	1(0.19%)	7.66053886991358e-15	6.32827124036339e-15	8.88178419700125e-16	0.00829153206826583	0.747663384064458
LGG	gender	FEMALE (vs MALE)	0.916038609219077	0.64206973705615	1.30690902428662	0.628610577668787	230/54--285/71	1(0.19%)	0.627979526016211	0.628610577668787	0.628503062623557	0.784210787681681	0.516293643688451
LGG	histological_grade_v2	G_1/2/Low (vs G_3/4/High)	0.299426054410966	0.202418233133555	0.442924338742567	1.57450641413703e-09	249/37--265/88	2(0.39%)	1.82014514571449e-10	1.57450641413703e-09	1.87202364720918e-10	0.0334790129344396	0.66323930519667
LGG	histological_type	Oligodendroglioma (vs Astrocytoma)	0.560924943934498	0.375405745556399	0.838124606381791	0.00477507738003669	191/42--194/58	NA	NA	NA	NA	0.141419246549132	NA
LGG	histological_type	Oligoastrocytoma (vs Astrocytoma)	0.606070926107136	0.37896989475261	0.969264241192954	0.0365931213580664	130/25--194/58	NA	NA	NA	NA	0.447427519388607	NA
LGG	histological_type	Global	NA	NA	NA	NA	NA	1(0.19%)	0.0104706608702488	0.00948699815748844	0.0084501147758228	0.328451810908043	0.594592658907789
LGG	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.0613255321255268	0.0226083989603109	0.166346183870921	4.18154949555216e-08	212/4--269/113	35(6.8%)	0	4.18154949555216e-08	1.09690034832965e-13	0.8739103823352	0.677022551648005
LGG	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	1.18259131414165	0.374680374565022	3.73257397830579	0.774893971828945	63/5--135/7	NA	NA	NA	NA	0.856187782866877	NA
LGG	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	3.18833065440788	1.40118394480158	7.25490211299596	0.00570830704683345	146/31--135/7	NA	NA	NA	NA	0.631692856982136	NA
LGG	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	8.50457280054659	3.88591091156574	18.6128195333882	8.48216481497133e-08	101/68--135/7	NA	NA	NA	NA	0.161806533023271	NA
LGG	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	71(13.79%)	7.56061879769732e-14	2.10257367072586e-11	2.72004641033163e-14	0.00363137964376226	0.756386693622496
LGG	treatment_outcome_first_course_v2	Complete_Remission/Response (vs Uncomplete_Remission/Response)	0.215116449954999	0.0997517888862752	0.463902327546214	8.89636154264295e-05	135/7--310/104	71(13.79%)	9.80162594088618e-07	8.89636154264295e-05	1.63564035513541e-05	0.545071184167955	0.610710347362617
LGG	new_tumor_event_dx_days_to	Yes (vs NO)	2.6027688494314	1.75113933444416	3.86857033607824	2.23651747588427e-06	165/89--350/36	1(0.19%)	7.43330685337718e-07	2.23651747588427e-06	1.00643085299001e-06	0.144759154824019	0.585138764547896
LGG	radiation_therapy	YES (vs NO)	1.42990090078761	0.970897744623423	2.10590311636398	0.0702272674496535	142/38--373/87	1(0.19%)	0.0770138011552346	0.0702272674496534	0.0688333404786303	0.774573105372026	0.536007162041182
LGG	targeted_molecular_therapy	YES (vs NO)	1.26119326378805	0.841036009311028	1.8912489251529	0.261636930226385	138/33--377/92	1(0.19%)	0.269904652520628	0.261636930226385	0.260616144302046	0.96386591607576	0.520483437779767
LGG	history_neoadjuvant_steroid_tx	YES (vs NO)	1.2705806500534	0.883657836379517	1.82692341065458	0.196206012719227	151/48--364/77	1(0.19%)	0.200654217776188	0.196206012719227	0.195167775701661	0.445429582707512	0.519015219337511
LGG	history_neoadjuvant_medication	NO (vs YES)	0.863507861797529	0.604319522100521	1.23386023472217	0.420294823148298	250/56--265/69	1(0.19%)	0.419202210154065	0.420294823148298	0.419892845708006	0.115425745967693	0.503115487914055
LGG	firstsymptomlongestduration	31-90Days (vs 0-30Days)	1.05689820239959	0.63751077646805	1.75218027909129	0.830116007050868	77/21--219/56	NA	NA	NA	NA	0.529242074207401	NA
LGG	firstsymptomlongestduration	91-180Days (vs 0-30Days)	1.3009023346301	0.69611838009865	2.43111937944553	0.409628429262864	37/12--219/56	NA	NA	NA	NA	0.623186612664189	NA
LGG	firstsymptomlongestduration	>181Days (vs 0-30Days)	0.591122160387354	0.361847041148901	0.96567159259214	0.035776438321207	111/23--219/56	NA	NA	NA	NA	0.493238418913402	NA
LGG	firstsymptomlongestduration	Global	NA	NA	NA	NA	NA	71(13.79%)	0.0684874298257748	0.0862661050081277	0.0794676650091121	0.745135124416574	0.554955586722768
LGG	histor_hay_fever	YES (vs NO)	0.409067773013868	0.150744453395214	1.11006699848393	0.0792671363826064	37/4--478/121	1(0.19%)	0.0425660752263103	0.0792671363826064	0.0696866616169127	0.657320001407894	0.526589077887198
LGG	idh1_mutation_found	NO (vs YES)	4.95002508588129	1.89158740869156	12.9535374565656	0.00111940394496468	38/14--91/7	386(74.95%)	0.000563596440590119	0.00111940394496468	0.000316434432312773	0.744011221787479	0.717817164179104
LIHC	AR	(continuous)	0.633111365308987	0.354008906637083	1.13225965044525	0.123276446788973	184/94	193(51.19%)	0.121376460232372	0.123276446788973	0.123552429779961	0.178239545263928	0.596425419240953
LIHC	AR	H (vs L)	0.490252680980725	0.323244437498894	0.743547802611796	0.000795501520903463	92/52--92/42	193(51.19%)	0.000758414550384834	0.000795501520903463	0.000630480176044279	0.152441614060651	0.608781994704325
LIHC	BMI	(continuous)	1.00185472913626	0.973016247639413	1.03154793224445	0.901041372879659	340/114	37(9.81%)	0.901360271454907	0.901041372879659	0.901044512657736	0.513181168528748	0.436687676592045
LIHC	age_at_initial_pathologic_diagnosis	(continuous)	1.01261760859237	0.999000320596659	1.02642051267703	0.0694974673036078	376/132	1(0.27%)	0.0641821067263515	0.0694974673036081	0.0692624975710823	0.182147774343054	0.527982638766364
LIHC	BMI_category	Over (vs Normal)	0.807565244874938	0.518215404435499	1.25847595256326	0.345035486232513	92/29--180/61	NA	NA	NA	NA	0.322032411451703	NA
LIHC	BMI_category	Obesity (vs Normal)	0.896435129591436	0.558128011230223	1.43980578898797	0.651106316811046	69/24--180/61	NA	NA	NA	NA	0.445139036291696	NA
LIHC	BMI_category	Global	NA	NA	NA	NA	NA	37(9.81%)	0.6257073428509	0.630131390640861	0.629233849156855	0.542950167196936	0.543055857422299
LIHC	gender	FEMALE (vs MALE)	1.21660051018623	0.855206750775147	1.73071225179623	0.275617589755562	122/51--255/81	1(0.27%)	0.279503754528768	0.275617589755562	0.274875126083044	0.207041163663639	0.506916263806062
LIHC	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.36648709430383	0.840713223302002	2.22107482925619	0.207711574028964	87/26--175/44	NA	NA	NA	NA	0.806987579714364	NA
LIHC	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.59001146281031	1.70619121907738	3.93165742648484	7.87017498160569e-06	86/45--175/44	NA	NA	NA	NA	0.86208352213333	NA
LIHC	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	5.44522576037974	1.68226332939922	17.6253521451318	0.0046857056237618	5/3--175/44	NA	NA	NA	NA	0.390703625449671	NA
LIHC	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	25(6.63%)	4.19348819798993e-05	1.52352206589379e-05	4.92787147021723e-06	0.820385343233769	0.608957055214724
LIHC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.40889520307898	1.66563257585782	3.48382721587226	3.0088317617416e-06	91/48--262/70	25(6.63%)	7.23855827666764e-06	3.0088317617416e-06	1.44229754428515e-06	0.678548510989146	0.590777096114519
LIHC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.08282507526554	0.75633845910384	1.55024530289401	0.663833944838082	137/48--235/80	6(1.59%)	0.664899767869629	0.663833944838082	0.663751799052649	0.0620324118151356	0.527946337183799
LIHC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	2.33573003976928	1.60407795118353	3.4011033033995	9.65858018120436e-06	154/80--202/43	22(5.84%)	5.1047060392051e-06	9.65858018120436e-06	5.25489067237928e-06	1.11231038646409e-06	0.549662430500397
LIHC	residual_tumor	R1 (vs R0)	1.44836970358566	0.705765410035445	2.972340055826	0.312531138505798	17/8--330/112	NA	NA	NA	NA	0.119715589892619	NA
LIHC	residual_tumor	R2 (vs R0)	10.7305103071621	1.46499609384933	78.5966951963452	0.0195006689518199	1/1--330/112	NA	NA	NA	NA	0.768632188980829	NA
LIHC	residual_tumor	RX (vs R0)	3.14605636840768	1.51256103271772	6.54365044391943	0.00215914195213807	22/8--330/112	NA	NA	NA	NA	0.603283215114439	NA
LIHC	residual_tumor	Global	NA	NA	NA	NA	NA	8(2.12%)	0.0151954708670219	0.00199008783655241	0.000353219038535357	0.407904787064522	0.535776068313151
LIHC	new_tumor_event_type	Intrahepatic_Recurrence (vs NO)	0.914824249771317	0.575950609921189	1.4530819024294	0.706108099094284	76/28--199/51	NA	NA	NA	NA	0.000326184146988484	NA
LIHC	new_tumor_event_type	Locoregional_Recurrence (vs NO)	1.70613877314642	1.09462948004457	2.65926467932787	0.0183116806553716	62/32--199/51	NA	NA	NA	NA	0.0180139369981112	NA
LIHC	new_tumor_event_type	Extrahepatic_Recurrence (vs NO)	1.35660148460497	0.761964782946751	2.41529218832809	0.300079810135405	29/15--199/51	NA	NA	NA	NA	0.00117142899808109	NA
LIHC	new_tumor_event_type	New_Primary_Tumor (vs NO)	1.55823835687245	0.663921462728518	3.65721988689711	0.308204915329938	11/6--199/51	NA	NA	NA	NA	0.26888946310152	NA
LIHC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.27%)	0.0975133447146259	0.0830691021238213	0.0767944125180777	0.000896018781367025	0.562122869543738
LIHC	new_tumor_event_dx_days_to	YES (vs NO)	1.2500132781259	0.879454662115987	1.77670693305731	0.213526267703858	179/81--198/51	1(0.27%)	0.210160507076126	0.213526267703858	0.212596016331661	9.43128315429309e-05	0.482903419316137
LIHC	eastern_cancer_oncology_group	1 (vs 0)	1.80566075649017	1.12438236772966	2.89973487765735	0.0144838447845199	86/33--166/36	NA	NA	NA	NA	0.978504792650394	NA
LIHC	eastern_cancer_oncology_group	2 (vs 0)	4.03403702180882	2.16317545529565	7.52294718095348	1.15129895024157e-05	26/14--166/36	NA	NA	NA	NA	0.841951078710315	NA
LIHC	eastern_cancer_oncology_group	3 (vs 0)	10.0622001570061	4.48144133524151	22.5927027546812	2.21139564438033e-08	12/8--166/36	NA	NA	NA	NA	0.407661055115728	NA
LIHC	eastern_cancer_oncology_group	4 (vs 0)	39.9243630384332	8.78842583288167	181.36976909572	1.80206719369025e-06	3/2--166/36	NA	NA	NA	NA	0.728794616133575	NA
LIHC	eastern_cancer_oncology_group	Global	NA	NA	NA	NA	NA	85(22.55%)	2.11511731462721e-08	5.18814990968508e-11	0	0.940002202294368	0.656285939107802
LIHC	risk_factors_Non.Alcoholic_Fatty_Liver_Disease	Yes (vs NO)	0.577951558577541	0.213400571440652	1.56526293161827	0.280788296018901	20/4--357/128	1(0.27%)	0.238813302640363	0.280788296018901	0.274786979651677	0.641358205899421	0.512809202865309
LIHC	risk_factors_Hepatitis_C_risk	Hepatitis_C (vs NO)	1.10921708004332	0.680485636163314	1.80806539517395	0.677559610117824	56/19--321/113	1(0.27%)	0.681211632427871	0.677559610117824	0.677424899761179	0.570048130630905	0.499206041144712
LIHC	risk_factors_Hepatitis_B	Hepatitis_B (vs NO)	0.356706210946424	0.221240048167387	0.575118844810082	2.33919471755994e-05	107/20--270/112	1(0.27%)	2.35914112267643e-06	2.33919471755994e-05	1.00948838878123e-05	0.0962986101164607	0.572814848794947
LIHC	alcohol	Yes (vs NO)	1.03938224913492	0.718252260050376	1.50408918969637	0.837684942053432	118/41--259/91	1(0.27%)	0.838074378842248	0.837684942053432	0.837675104892842	0.00667494627566367	0.477310420268887
LIHC	viral_hepatitis_serology	Yes (vs NO)	1.85062681659669	1.30953401112669	2.61529642239698	0.000486278560949294	166/73--211/59	1(0.27%)	0.000470607220469987	0.000486278560949294	0.000398391530463837	0.0201651476069419	0.605243657150923
LIHC	viral_hepatitis_serology_HC	Yes (vs NO)	1.82779262036676	1.29444099482593	2.58090239448607	0.000612547601416158	147/67--230/65	1(0.27%)	0.000663358332147479	0.000612547601416158	0.000510703441428673	0.00995981486620767	0.606249338367621
LIHC	viral_hepatitis_serology_HB	Yes (vs NO)	2.49228390666583	1.72961132684415	3.59125716571189	9.60312277031861e-07	104/48--273/84	1(0.27%)	2.94960719526838e-06	9.60312277031861e-07	4.22206655414925e-07	0.523857126169623	0.606178764247151
LIHC	vascular_invasion	Micro (vs None)	1.19856115494234	0.765731883030098	1.87604679127649	0.4281777610482	94/28--210/62	NA	NA	NA	NA	0.88214606049512	NA
LIHC	vascular_invasion	Macro (vs None)	2.06924971142197	0.984248403249733	4.35031883626383	0.0551001600888654	17/8--210/62	NA	NA	NA	NA	0.771556680056352	NA
LIHC	vascular_invasion	Global	NA	NA	NA	NA	NA	57(15.12%)	0.187575495932214	0.145067367106623	0.135629334396215	0.938047386181678	0.542280837858805
LIHC	alpha_fetoprotien_norm_range_lower	NO (vs Yes)	0.595908865274592	0.369309105278988	0.961545141012954	0.0339553613800883	119/25--150/53	109(28.91%)	0.0296255253064655	0.0339553613800883	0.032059690898172	0.756323412009456	0.56675911251981
LIHC	platelet_count_preresection	Low (vs Normal)	1.34213622214921	0.824777510973287	2.18401885943676	0.236210311732209	69/22--221/64	NA	NA	NA	NA	0.4831019576904	NA
LIHC	platelet_count_preresection	High (vs Normal)	2.15933970114574	1.1605642845244	4.01765589990989	0.0150983187625267	20/12--221/64	NA	NA	NA	NA	0.750368729371751	NA
LIHC	platelet_count_preresection	Global	NA	NA	NA	NA	NA	68(18.04%)	0.0591723436045151	0.0403864764811319	0.0356774010631623	0.76904578855575	0.554853051561868
LIHC	bilirubin_total	H (vs Normal)	1.49434383339401	0.878789207315431	2.54106840845756	0.138088637558987	49/17--252/73	NA	NA	NA	NA	0.811095143687348	NA
LIHC	bilirubin_total	L (vs Normal)	5.45175450629946	0.749782405364381	39.6403369621781	0.0938425304510069	1/1--252/73	NA	NA	NA	NA	0.5910827062891	NA
LIHC	bilirubin_total	Global	NA	NA	NA	NA	NA	76(20.16%)	0.161165554768597	0.0935338219750969	0.0670635236391222	0.834614153599664	0.537609642203572
LUAD	AR	(continuous)	0.725500649567511	0.394078128682501	1.33565187766852	0.30276611846701	354/141	168(32.18%)	0.293017755751632	0.30276611846701	0.30355588825663	0.517896640620502	0.50492771407754
LUAD	AR	H (vs L)	0.940001820501154	0.6747712590331	1.30948586015893	0.714505043707964	177/69--177/72	168(32.18%)	0.71458197842157	0.714505043707964	0.714462476607935	0.784559554821167	0.501169613068988
LUAD	tobacco_smoking_history	(continuous)	1.03665201442248	0.901505532651729	1.1920585732238	0.613506895984424	499/174	23(4.41%)	0.612851244389517	0.613506895984424	0.613450511634445	0.276374783805333	0.522436722436722
LUAD	age_at_initial_pathologic_diagnosis	(continuous)	1.00835225908778	0.993157632365774	1.02377935311779	0.282967057138564	503/181	19(3.64%)	0.280079035217179	0.282967057138564	0.282887496744822	0.268675916813124	0.519693586403672
LUAD	tobacco_smoking_history_v2	No (vs Yes)	1.20978285491556	0.63725545699905	2.29668422604	0.560377134625841	14/10--508/178	9(1.72%)	0.571038729287493	0.560377134625841	0.559788747881571	0.338859356399262	0.500516929439132
LUAD	gender	MALE (vs FEMALE)	1.07343190661427	0.803220075798995	1.43454588954509	0.631985638533877	242/90--280/98	9(1.72%)	0.632196961276453	0.631985638533877	0.631915415349828	0.0410869256176433	0.53167186909756
LUAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.41605330488002	1.6820229803598	3.47041249743986	1.80339629418658e-06	124/54--279/69	NA	NA	NA	NA	0.173194568367295	NA
LUAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	3.55365231037372	2.43198527086096	5.19264853053727	5.65480995362577e-11	85/47--279/69	NA	NA	NA	NA	0.0199937794352051	NA
LUAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	3.84885465420763	2.2199259759796	6.67305230422327	1.58459585264392e-06	26/16--279/69	NA	NA	NA	NA	0.915477215719868	NA
LUAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	17(3.26%)	6.19759799036501e-12	9.09938790982778e-12	4.70512517836141e-13	0.109460722408182	0.667085170667973
LUAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.64749740545337	1.94354476902119	3.60642194798134	6.67767396933527e-10	111/63--403/123	17(3.26%)	6.75260780624853e-09	6.67767396933527e-10	1.40912614909894e-10	0.236867082952636	0.607014535358484
LUAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.37428129007169	4.37187089537304	9.29383848181798	0	171/116--294/36	65(12.45%)	0	0	0	0.280815685853268	0.698471539474038
LUAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	2.57278887786283	0.630052587449253	10.5058573552606	0.188028321646338	6/2--320/89	NA	NA	NA	NA	0.578881647232475	NA
LUAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	1.12236078054607	0.563440231963546	2.23571844935184	0.742677981889174	37/9--320/89	NA	NA	NA	NA	0.998409558058432	NA
LUAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	4.126500906861	2.86782989266154	5.93759405950033	2.26485497023532e-14	68/46--320/89	NA	NA	NA	NA	0.0187649085517634	NA
LUAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	98(18.77%)	1.02164499082846e-10	6.07958128284736e-13	4.21884749357559e-15	0.0963915591938987	0.654505649285036
LUAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	2.85207951136759	2.02967265761919	4.00771893370452	1.55561175052554e-09	111/57--320/89	98(18.77%)	8.95553375901414e-09	1.55561175052554e-09	2.78266520936654e-10	0.0339729622340734	0.638491686824459
LUAD	residual_tumor	R1 (vs R0)	3.40056876440989	1.76723608347862	6.54347657881562	0.00024727044426931	13/10--348/134	NA	NA	NA	NA	0.363029206029156	NA
LUAD	residual_tumor	R2 (vs R0)	5.77587765090857	1.81428801169077	18.3877986423861	0.00299547120180532	5/3--348/134	NA	NA	NA	NA	0.98298429929698	NA
LUAD	residual_tumor	RX (vs R0)	1.18381396771652	0.549659579601542	2.54960626935064	0.666406833000804	26/7--348/134	NA	NA	NA	NA	0.592742223280592	NA
LUAD	residual_tumor	Global	NA	NA	NA	NA	NA	139(26.63%)	0.00186210305282553	0.000104321422045306	1.62760828220643e-05	0.79069207927832	0.536896451893074
LUAD	new_tumor_event_type	Distant_Metastasis (vs NO)	2.43099452841306	1.67464385463022	3.52894997992227	2.991285446452e-06	63/38--391/118	NA	NA	NA	NA	0.0590730213069717	NA
LUAD	new_tumor_event_type	Locoregional_Recurrence (vs NO)	1.16280361529602	0.742097629576053	1.82201396939905	0.510372412583354	48/23--391/118	NA	NA	NA	NA	0.0602846978197868	NA
LUAD	new_tumor_event_type	New_Primary_Tumor (vs NO)	0.152813088982532	0.0212862717042897	1.09703758783072	0.0617793209496602	11/1--391/118	NA	NA	NA	NA	0.322602119366564	NA
LUAD	new_tumor_event_type	Locoregional_Recurrence|Distant_Metastasis (vs NO)	1.72664752699883	0.802118824281412	3.71679555726922	0.162631689665075	8/7--391/118	NA	NA	NA	NA	0.563711823867499	NA
LUAD	new_tumor_event_type	Distant_Metastasis|New_Primary_Tumor (vs NO)	8.2638879950743	1.14207497505154	59.7962885860896	0.0364806093211771	1/1--391/118	NA	NA	NA	NA	0.615443334072218	NA
LUAD	new_tumor_event_type	Global	NA	NA	NA	NA	NA	9(1.72%)	1.09927778797481e-05	1.24148090040466e-05	1.31419157667345e-06	0.231682781169281	0.564327892319621
LUAD	new_tumor_event	Yes (vs NO)	1.98949110460994	1.48285993613542	2.66921693604959	4.49149781833746e-06	187/108--335/80	9(1.72%)	3.58153471013978e-06	4.49149781833746e-06	2.90600975760835e-06	0.0179264642916849	0.556723064993936
LUAD	other_dx	Yes (vs No)	1.42688538534369	0.974238883187463	2.08983847600718	0.0678632554419828	93/33--429/155	9(1.72%)	0.0783860706410597	0.0678632554419827	0.066465636536043	0.862555709783714	0.523629639938764
LUAD	targeted_molecular_therapy	YES (vs No)	1.38633148615582	0.801144899949017	2.39896052465579	0.242996249062222	38/14--484/174	9(1.72%)	0.264152240785001	0.242996249062222	0.240912375008876	0.791415276526499	0.514762311867507
LUAD	egfr_mutation_status	YES (vs NO)	1.33046300946657	0.843840182516261	2.09770979888688	0.219042660501646	80/26--197/84	247(47.32%)	0.229260230541548	0.219042660501646	0.217596623232259	0.874701091178491	0.526993993574522
LUAD	eml4_alk_translocation_status	YES (vs NO)	1.84656204202011	1.02942200845246	3.31233580303518	0.0396643096172721	34/14--213/87	277(53.07%)	0.0537775508423486	0.0396643096172721	0.0366920192558313	0.516388828845995	0.547715609998345
LUSC	AR	(continuous)	1.55882932154755	0.805229903242794	3.0177081649981	0.187769655047194	320/133	184(36.51%)	0.195674006143419	0.187769655047194	0.187950472132943	0.773229128694734	0.534774515610458
LUSC	AR	H (vs L)	1.30368103910813	0.923242812135605	1.8408854413918	0.131982496570925	162/58--158/75	184(36.51%)	0.130220954237614	0.131982496570925	0.130865096784047	0.751490894376397	0.530057534478382
LUSC	tobacco_smoking_history	(continuous)	0.801318666213974	0.695690762697301	0.9229842327263	0.00213197257418551	486/212	18(3.57%)	0.00244671458659629	0.00213197257418551	0.00201128710986154	0.399389688947104	0.563293567422402
LUSC	age_at_initial_pathologic_diagnosis	(continuous)	1.01686596569129	1.00053920845028	1.03345914227873	0.0428429143686839	492/215	12(2.38%)	0.0397184896380942	0.0428429143686839	0.0427988964370136	0.416620761387583	0.532092734055783
LUSC	tobacco_smoking_history_v2	No (vs Yes)	0.44789246621673	0.143237446540595	1.40052525466411	0.167322412569086	12/3--492/216	6(1.19%)	0.113106447579864	0.167322412569086	0.156112755790178	0.554656250934286	0.506596421332215
LUSC	gender	FEMALE (vs MALE)	0.838625903963728	0.610371088171723	1.15223905658047	0.277596620517106	131/51--373/168	6(1.19%)	0.270391396643137	0.277596620517106	0.276983120520825	0.635750997925731	0.519885370797512
LUSC	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.56541162634493	1.13950368587843	2.15050955101281	0.00567509372077402	92/50--408/167	10(1.98%)	0.0079403530105161	0.00567509372077402	0.0052848940185638	0.292132425966306	0.543917963224894
LUSC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	3.95101954135217	2.88922562521015	5.40302400751801	0	114/91--319/76	77(15.28%)	0	0	0	0.000301016321848535	0.622993186623855
LUSC	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	9.1049662166569	2.83162150250752	29.2766564080164	0.000210054460243358	4/3--311/102	NA	NA	NA	NA	0.683742971374835	NA
LUSC	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	2.36720730644388	1.14767631501047	4.88262270327514	0.0196556433778994	17/8--311/102	NA	NA	NA	NA	0.740869944977154	NA
LUSC	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	4.52391983948571	2.85086498920641	7.17882144246663	1.48716705616891e-10	31/24--311/102	NA	NA	NA	NA	0.86345019088193	NA
LUSC	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	145(28.77%)	1.35093792819063e-08	2.32355246154725e-11	5.79536418854332e-14	0.956060338687636	0.604360552386671
LUSC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	3.84337406812696	2.58574503128051	5.71267624953559	2.77639022883136e-11	52/35--311/102	145(28.77%)	3.1539240108458e-09	2.77639022883136e-11	8.23341395062016e-13	0.641856931752915	0.602221555088562
LUSC	residual_tumor	R1 (vs R0)	4.35746275247815	1.89004431353528	10.0460510387287	0.00055292428583964	12/6--401/177	NA	NA	NA	NA	0.981095886161557	NA
LUSC	residual_tumor	R2 (vs R0)	1.89574091695827e-07	0	Inf	0.993329031874248	4/0--401/177	NA	NA	NA	NA	0.999847736768666	NA
LUSC	residual_tumor	RX (vs R0)	1.81591985552829	0.955821744108058	3.44997897571275	0.0684589418849424	23/11--401/177	NA	NA	NA	NA	0.377935656017116	NA
LUSC	residual_tumor	Global	NA	NA	NA	NA	NA	69(13.69%)	0.0031383084439619	0.00229725439260309	0.000339209232595783	0.854605097251015	0.533036529680365
LUSC	new_tumor_event_dx_days_to	Yes (vs NO)	1.81305549504167	1.38340402833446	2.37614620224748	1.61908878211214e-05	133/94--371/125	6(1.19%)	2.36145173606594e-05	1.61908878211214e-05	1.21155674288609e-05	0.00716290042727286	0.540399804291606
LUSC	other_dx	Yes (vs No)	1.36699169721399	0.958557075441368	1.94945752123478	0.0843042928250711	70/37--433/182	7(1.39%)	0.0953169656931092	0.0843042928250711	0.0830516068019514	0.984939806500326	0.519107779408681
LUSC	targeted_molecular_therapy	YES (vs NO)	0.725932052136148	0.428877076090883	1.22873749541915	0.232932675516896	51/16--453/203	6(1.19%)	0.211796520714917	0.232932675516896	0.230943252997073	0.937464701744519	0.513778220451527
LUSC	eastern_cancer_oncology_group	1 (vs 0)	1.14647974399784	0.716711534192013	1.8339537466481	0.568466807925255	93/46--70/30	NA	NA	NA	NA	0.565742445315877	NA
LUSC	eastern_cancer_oncology_group	2 (vs 0)	0.76319008808959	0.333903607180497	1.74439298657633	0.521687024153749	26/7--70/30	NA	NA	NA	NA	0.841314920202414	NA
LUSC	eastern_cancer_oncology_group	3 (vs 0)	5.35647597251698	1.83155415810578	15.6652942623467	0.00217506310987359	5/4--70/30	NA	NA	NA	NA	0.788800060724216	NA
LUSC	eastern_cancer_oncology_group	Global	NA	NA	NA	NA	NA	312(61.9%)	0.0552533772782045	0.0134611021829025	0.00434340786072174	0.881457015594172	0.568965517241379
MESO	AR	(continuous)	0.614533141898911	0.321470915086766	1.17475940985273	0.140812331851655	60/56	27(31.03%)	0.117781251287888	0.140812331851656	0.139491411319057	0.651525407377574	0.550351288056206
MESO	AR	H (vs L)	0.773465224918623	0.454772541042457	1.31548939341649	0.343131459359542	30/29--30/27	27(31.03%)	0.342658724181246	0.343131459359542	0.341830333711603	0.902399251440311	0.535421545667447
MESO	age_at_initial_pathologic_diagnosis	(continuous)	1.02093647317046	0.99146705144471	1.05128181590194	0.165587435413928	86/73	1(1.15%)	0.161342042280455	0.165587435413928	0.165332897815028	0.811286616777523	0.55307855626327
MESO	gender	FEMALE (vs MALE)	1.1264506983753	0.626813926393111	2.02435064449161	0.690532453157033	16/14--71/60	1(1.15%)	0.694041637994758	0.690532453157033	0.690361142262085	0.398054383761695	0.519714892326357
MESO	pathologic_stage_v2	StageIII/IV (vs StageI/II)	0.992724723965018	0.588276351748178	1.67523711371842	0.978180067745991	61/52--26/22	1(1.15%)	0.978191422572445	0.978180067745991	0.978180022390244	0.189406401130186	0.518198362147407
MESO	histological_type	Biphasic_mesothelioma (vs Epithelioid_mesothelioma)	2.0113693379076	1.18727571035062	3.40747020949341	0.00937132856421197	23/21--57/46	NA	NA	NA	NA	0.238773091629099	NA
MESO	histological_type	Diffuse_malignant_mesothelioma_-_NOS (vs Epithelioid_mesothelioma)	1.1574952630332	0.45804001380697	2.925061661772	0.75715695927408	5/5--57/46	NA	NA	NA	NA	0.643489439215499	NA
MESO	histological_type	Sarcomatoid_mesothelioma (vs Epithelioid_mesothelioma)	6.8749136800091	0.89322008138964	52.9146613386076	0.0640955523316505	2/2--57/46	NA	NA	NA	NA	0.834781132339652	NA
MESO	histological_type	Global	NA	NA	NA	NA	NA	1(1.15%)	0.0483049567723668	0.0254646885709146	0.015798295841884	0.584021547356009	0.589323627540188
MESO	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.6220783699934	0.302486134900862	1.27933631913568	0.196933089555422	16/10--50/43	21(24.14%)	0.175251816523116	0.196933089555422	0.192824268703531	0.599189175144805	0.531665779670037
MESO	new_tumor_event_type	Intrapleural_Progression (vs NO)	0.67378381843574	0.387910813041519	1.17033250614041	0.161027669229266	25/20--43/36	NA	NA	NA	NA	0.589417097883169	NA
MESO	new_tumor_event_type	Distant_Metastasis (vs NO)	0.626577976434095	0.29520333456473	1.32993064299603	0.223440959214311	10/9--43/36	NA	NA	NA	NA	0.792214265866735	NA
MESO	new_tumor_event_type	Locoregional_Recurrence (vs NO)	0.759015917505768	0.34640418121863	1.66310106592945	0.490853064602714	9/9--43/36	NA	NA	NA	NA	0.507523688737064	NA
MESO	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(1.15%)	0.429847491067096	0.430654363466757	0.424793014996119	0.784937012191934	0.55459508644222
MESO	new_tumor_event_dx_days_to	NO (vs Yes)	1.36868451185947	0.854935731136372	2.1911556913337	0.19114919909605	40/33--47/41	1(1.15%)	0.194191986460977	0.19114919909605	0.189391099286778	0.78190828896138	0.543221110100091
OV	AR	(continuous)	0.772333912866472	0.633272965817252	0.941931371085517	0.0107537216905026	407/246	180(30.66%)	0.00980441056643411	0.0107537216905026	0.0106515195345435	0.376870563906626	0.564024921575462
OV	AR	H (vs L)	0.734190573285486	0.570399741227028	0.945014099658798	0.0164363199730571	206/138--201/108	180(30.66%)	0.0159832047756949	0.0164363199730571	0.0160182762483593	0.312392606677917	0.547991460439177
OV	age_at_initial_pathologic_diagnosis	(continuous)	1.02416611511893	1.01430107873806	1.03412709829986	1.32888169279699e-06	582/348	5(0.85%)	1.44180574357389e-06	1.32888169279699e-06	1.223040704601e-06	0.00479796742750516	0.598338836677673
OV	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	1.43165291628935	0.927157912106471	2.21065909696345	0.105496406213877	34/22--498/311	NA	NA	NA	NA	0.775953738142707	NA
OV	race	ASIAN (vs WHITE)	0.844821810341693	0.375956658225566	1.89842067061038	0.683119637828139	20/6--498/311	NA	NA	NA	NA	0.125253424232246	NA
OV	race	AMERICAN_INDIAN_OR_ALASKA_NATIVE (vs WHITE)	6.92561204791288	2.20051329257769	21.7967791423839	0.000938964309147416	3/3--498/311	NA	NA	NA	NA	0.875110033866031	NA
OV	race	NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER (vs WHITE)	6.24428562936829	0.867945739282185	44.9234338697049	0.0688665065499222	1/1--498/311	NA	NA	NA	NA	0.747427051612085	NA
OV	race	Global	NA	NA	NA	NA	NA	32(5.45%)	0.0285351346634858	0.00231946195572352	0.000275059859140336	0.62972676477816	0.524644869624837
OV	clinical_stage_v2	StageIII/IV (vs StageI/II)	2.15979095404346	1.2134793326671	3.84406791248389	0.00885070449232761	535/335--47/12	9(1.53%)	0.00305165137020447	0.00885070449232761	0.00729907848917366	0.296222958395665	0.52249129617648
OV	histological_grade_v2	G_1/2/Low (vs G_3/4/High)	0.818095548884598	0.597101538050893	1.1208819345693	0.211416671063308	75/45--496/295	NA	NA	NA	NA	0.0134144150604344	NA
OV	histological_grade_v2	GX (vs G_3/4/High)	0.92813317782569	0.413434468713995	2.08359791204718	0.856558007287977	10/6--496/295	NA	NA	NA	NA	0.733205835704923	NA
OV	histological_grade_v2	GB (vs G_3/4/High)	2.95683384100303	0.733997838506476	11.911297151897	0.127268456797367	2/2--496/295	NA	NA	NA	NA	0.982400645166021	NA
OV	histological_grade_v2	Global	NA	NA	NA	NA	NA	8(1.36%)	0.332401279890797	0.258953144543929	0.231013036413006	0.103706430310974	0.527035863901093
OV	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.0913712760368343	0.0484303640487402	0.172385862641818	1.49213974509621e-13	120/10--398/302	70(11.93%)	0	1.49213974509621e-13	0	0.035662491366562	0.603201008191556
OV	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	3.81803365781941	2.77470320622971	5.25367216915777	2.22044604925031e-16	65/57--331/168	NA	NA	NA	NA	0.555015446207873	NA
OV	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	3.36406722678204	2.07420037570416	5.4560535418219	8.78866599940409e-07	31/19--331/168	NA	NA	NA	NA	0.986990512904832	NA
OV	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	5.86079127016313	4.02646162212349	8.53078398256417	0	42/36--331/168	NA	NA	NA	NA	0.150634029626726	NA
OV	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	119(20.27%)	0	0	0	0.371748454833894	0.660693796073623
OV	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	4.18701469695013	3.22896496695213	5.42932247698688	0	138/112--331/168	119(20.27%)	0	0	0	0.714175557798366	0.652190314518791
OV	new_tumor_event_type	Progression_of_Disease (vs NO)	2.11580841437136	1.38942436574233	3.22194237894546	0.000478063546838436	34/28--259/102	NA	NA	NA	NA	0.119444532371338	NA
OV	new_tumor_event_type	Recurrence (vs NO)	1.36304080599388	1.07535336437783	1.72769277555509	0.0104494116886464	294/219--259/102	NA	NA	NA	NA	6.7708116890941e-10	NA
OV	new_tumor_event_type	Global	NA	NA	NA	NA	NA	5(0.85%)	0.00125936480719779	0.000963100373724157	0.000825010982870911	3.49991624570833e-09	0.509225298450597
OV	new_tumor_event_dx_days_to	NO (vs Yes)	0.929719648084096	0.726773618471395	1.1893368196986	0.561938159136352	225/86--362/263	5(0.85%)	0.559572401761339	0.561938159136352	0.56185485933607	1.90239590747154e-09	0.464851409702819
OV	anatomic_neoplasm_subdivision	Left (vs Bilateral)	0.740540505717023	0.53146336438835	1.03186837956134	0.0759602178863454	82/42--400/247	NA	NA	NA	NA	0.598414977225395	NA
OV	anatomic_neoplasm_subdivision	Right (vs Bilateral)	1.27779794539826	0.914211822713292	1.78598389202419	0.151304697949168	71/40--400/247	NA	NA	NA	NA	0.647171016159988	NA
OV	anatomic_neoplasm_subdivision	Global	NA	NA	NA	NA	NA	36(6.13%)	0.0455182932536947	0.0486537245406357	0.0470713124016762	0.807579076362679	0.531347462836069
OV	vascular_invasion_indicator	YES (vs NO)	0.863107037554914	0.618101094500454	1.20522963784571	0.38748741940282	91/39--496/310	5(0.85%)	0.378528476475486	0.38748741940282	0.387061297973578	0.208601605910422	0.502717805435611
OV	lymphovascular_invasion_indicator	YES (vs NO)	1.2422276411348	0.947501029646785	1.62863096093371	0.116483988144413	138/67--449/282	5(0.85%)	0.124573195721232	0.116483988144413	0.115789115298428	0.493093668903879	0.520472440944882
PAAD	AR	(continuous)	0.808196708907388	0.296220585003722	2.20505242834669	0.677530822150978	105/63	80(43.24%)	0.673334444614192	0.677530822150978	0.677606149121759	0.331853944916221	0.493033226152197
PAAD	AR	H (vs L)	1.01031550760775	0.61282801519779	1.66561808468118	0.967906369693305	53/31--52/32	80(43.24%)	0.967906432733269	0.967906369693305	0.967906232329631	0.969128379869504	0.502143622722401
PAAD	tobacco_smoking_history	(continuous)	0.921543921958531	0.787468615354913	1.07844704352561	0.308431574944873	149/80	36(19.46%)	0.302787868660014	0.308431574944873	0.307527099232944	0.521632210175496	0.527869343721906
PAAD	age_at_initial_pathologic_diagnosis	(continuous)	1.02817712286917	1.00826335189111	1.04848420207748	0.00535849444698622	185/100	0(0%)	0.00435332145959377	0.00535849444698622	0.00514848345694396	0.267443602576697	0.562982998454405
PAAD	tobacco_smoking_history_v2	No (vs Yes)	1.09353591595268	0.668688416777555	1.78830793157925	0.721607474435147	36/20--149/80	0(0%)	0.723957201846277	0.721607474435147	0.721518923578436	0.731932476927881	0.504057187017002
PAAD	gender	FEMALE (vs MALE)	1.19876627021488	0.809154287775099	1.77597844109098	0.365991850794666	83/49--102/51	0(0%)	0.366603163522306	0.365991850794666	0.365345082220952	0.180461051436801	0.506472179289026
PAAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	2.44747152568767	1.12460816123336	5.32640352038931	0.0240735328701726	152/88--21/7	NA	NA	NA	NA	0.0112240362104051	NA
PAAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	1.96026398169348	0.403121350708427	9.53220381696952	0.404224276950526	4/2--21/7	NA	NA	NA	NA	0.0684297377675239	NA
PAAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	2.43913878735965	0.621488429160736	9.57282186578503	0.201196708805205	5/3--21/7	NA	NA	NA	NA	0.00888041995921052	NA
PAAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	3(1.62%)	0.0868938428658605	0.161002415055065	0.139855987178419	0.0276398614476306	0.527849228333993
PAAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	0.985532612407703	0.398993406456594	2.43431223273815	0.974800943583347	9/5--173/95	3(1.62%)	0.974747028441692	0.974800943583347	0.974800714590074	0.106740471492129	0.509200633161852
PAAD	histological_grade	G2 (vs G1)	1.93018938208541	1.02026169938577	3.65164256676323	0.0432146690183498	97/52--32/12	NA	NA	NA	NA	0.395116798297344	NA
PAAD	histological_grade	G3 (vs G1)	2.61481224199686	1.33918051760143	5.10554250978996	0.00487117460935349	51/33--32/12	NA	NA	NA	NA	0.122112315239889	NA
PAAD	histological_grade	G4 (vs G1)	1.62773123433582	0.210060515266519	12.6130747031197	0.640966444445423	2/1--32/12	NA	NA	NA	NA	0.336251238537561	NA
PAAD	histological_grade	GX (vs G1)	3.06399081595987	0.680263895519523	13.8005850113752	0.144780470385867	3/2--32/12	NA	NA	NA	NA	0.058181487445319	NA
PAAD	histological_grade	Global	NA	NA	NA	NA	NA	0(0%)	0.0525496776241096	0.077561101832381	0.0660522811027167	0.13620222168821	0.599690880989181
PAAD	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.55478111928745	1.0242979541547	2.36000112963972	0.0381988849969179	53/34--129/64	NA	NA	NA	NA	0.319079924243724	NA
PAAD	histological_grade_v2	GX (vs G_1/2/Low)	1.85225105853367	0.451578351513886	7.59742793767123	0.392013534962263	3/2--129/64	NA	NA	NA	NA	0.0979553908618677	NA
PAAD	histological_grade_v2	Global	NA	NA	NA	NA	NA	0(0%)	0.106618184168654	0.0947486859383075	0.090883967688915	0.180175548706562	0.564625193199382
PAAD	histological_type	Pancreas-Adenocarcinoma-Other_Subtype (vs Pancreas-Adenocarcinoma_Ductal_Type)	0.227994952347611	0.0992894686642828	0.523536876521613	0.00049070441109178	25/6--154/92	NA	NA	NA	NA	0.164155792197453	NA
PAAD	histological_type	Pancreas-Colloid_(mucinous_non-cystic)_Carcinoma (vs Pancreas-Adenocarcinoma_Ductal_Type)	0.928583082050232	0.227799390271797	3.78520126520576	0.917686600409428	4/2--154/92	NA	NA	NA	NA	0.247001745688406	NA
PAAD	histological_type	Pancreas-Undifferentiated_Carcinoma (vs Pancreas-Adenocarcinoma_Ductal_Type)	2.49145073431017e-07	0	Inf	0.995895560831494	1/0--154/92	NA	NA	NA	NA	0.999825453885442	NA
PAAD	histological_type	Global	NA	NA	NA	NA	NA	1(0.54%)	0.000218712328749149	0.00688170711673997	0.00192598218765339	0.367903965400569	0.559394409937888
PAAD	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.255161789811816	0.140837836020915	0.462287271797477	6.64987995790955e-06	58/13--105/77	22(11.89%)	2.11942091543627e-07	6.64987995790955e-06	1.326404740154e-06	0.00431069287547214	0.593957303099747
PAAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	3.17877603726149	1.19850543165845	8.43101485246122	0.0201357859538417	10/5--70/26	NA	NA	NA	NA	0.878543471002701	NA
PAAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	1.43779381843729	0.548293916484526	3.77033376111665	0.460381671718237	8/5--70/26	NA	NA	NA	NA	0.211274865706845	NA
PAAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	2.93990998068565	1.7914283553933	4.82468119281139	1.98372889431697e-05	56/46--70/26	NA	NA	NA	NA	0.0199392256228917	NA
PAAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	41(22.16%)	0.000117145846952549	0.000215721016743387	9.55298470473043e-05	0.10051575151996	0.610270584812336
PAAD	treatment_outcome_first_course_v2	Complete_Remission/Response (vs Uncomplete_Remission/Response)	0.372830397805413	0.231305541197111	0.600947581317513	5.10542311537021e-05	70/26--74/56	41(22.16%)	2.26054590711788e-05	5.10542311537021e-05	2.58675236849415e-05	0.0424658414313132	0.593322665114926
PAAD	residual_tumor	R1 (vs R0)	1.6290525746976	1.0503839461062	2.52651642379592	0.0292942554077297	53/32--111/56	NA	NA	NA	NA	0.198147321906629	NA
PAAD	residual_tumor	R2 (vs R0)	1.00225760850274	0.243938775206164	4.11791980570804	0.997504396782661	5/2--111/56	NA	NA	NA	NA	0.838717620890634	NA
PAAD	residual_tumor	RX (vs R0)	2.17428235124631	0.677009647642944	6.98291931200733	0.191989577606121	4/3--111/56	NA	NA	NA	NA	0.317542954942991	NA
PAAD	residual_tumor	Global	NA	NA	NA	NA	NA	12(6.49%)	0.139293132415222	0.120308911620463	0.112982408824995	0.362208401086203	0.568889622537691
PAAD	new_tumor_event_type	Distant_Metastasis (vs NO)	1.10211114538217	0.712961208796397	1.70366769157909	0.6617373770997	59/38--101/44	NA	NA	NA	NA	0.00525023363215105	NA
PAAD	new_tumor_event_type	Locoregional_Recurrence (vs NO)	2.10624564198364	1.18229564933564	3.75225156826712	0.0114601332236078	21/16--101/44	NA	NA	NA	NA	0.27177154924685	NA
PAAD	new_tumor_event_type	Locoregional_Recurrence|Distant_Metastasis (vs NO)	1.09461732009295	0.149892218133697	7.9936576585901	0.928987371906354	2/1--101/44	NA	NA	NA	NA	0.27025748594232	NA
PAAD	new_tumor_event_type	New_Primary_Tumor (vs NO)	0.466280179177996	0.0616466328096145	3.52683018658491	0.459870406770099	2/1--101/44	NA	NA	NA	NA	0.0815487452756961	NA
PAAD	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	0.155469332584724	0.118159193409561	0.103351906476325	0.0312111513602923	0.532167697063369
PAAD	new_tumor_event_dx_days_to	Yes (vs NO)	1.24306975615039	0.836537845683676	1.84716379136791	0.281602073915191	84/56--101/44	0(0%)	0.27998428150667	0.281602073915191	0.280670138061796	0.0136148357016562	0.499227202472952
PAAD	radiation_therapy	YES (vs NO)	0.409494545580108	0.218614852932308	0.76703746616787	0.00529992021798376	33/11--152/89	0(0%)	0.00179871397546483	0.00529992021798376	0.00396182593203209	0.050343726445909	0.573560664605873
PAAD	targeted_molecular_therapy	NO (vs YES)	1.8192362332315	1.22472296175288	2.70234214239396	0.0030363266154233	91/56--94/44	0(0%)	0.00290547225037374	0.0030363266154233	0.0026307301113967	0.00458143886957252	0.606694358578053
PAAD	number_of_lymphnodes_positive_by_he	NO (vs Yes)	0.4398673994881	0.268616008396041	0.720297089841184	0.00109922343102931	53/20--132/80	0(0%)	0.000448111476810675	0.00109922343102931	0.000800537358029207	0.377208485368842	0.567668083462133
PAAD	alcohol_history_documented	NO (vs YES)	0.962697759544255	0.649461593945798	1.42700813238369	0.849854006184543	83/47--102/53	0(0%)	0.849801853059623	0.849854006184543	0.849845189053878	0.0702714396400546	0.526758114374034
PAAD	diabetes_diagnosis_indicator	YES (vs NO)	0.893492104613359	0.522543255688465	1.52777427000678	0.680725129140384	38/16--147/84	0(0%)	0.676936546274331	0.680725129140384	0.680566341039798	0.849771438449254	0.510142967542504
PCPG	AR	(continuous)	0.00894991604993815	7.00877735114137e-05	1.14286691227103	0.05665092742946	80/2	99(55.31%)	0.013262712674929	0.05665092742946	0.0291451112848395	0.766435947398256	0.929577464788732
PCPG	AR	H (vs L)	1.68114768979111e-09	0	Inf	0.999064899153779	40/2--40/0	99(55.31%)	0.0958216358122564	0.999064899153779	0.157179077551535	0.999998714349286	0.753521126760563
PCPG	age_at_initial_pathologic_diagnosis	(continuous)	1.0215391835514	0.971093791477996	1.07460506151789	0.409511078122955	179/6	0(0%)	0.409169658313521	0.409511078122955	0.406070101119948	0.425750359039577	0.650621118012422
PCPG	gender	MALE (vs FEMALE)	3.13148246802811	0.550497007982049	17.8133256046456	0.198106512100771	78/4--101/2	0(0%)	0.180850901763398	0.198106512100771	0.177094258906977	0.243447505964592	0.696428571428571
PCPG	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	14.521226278994	2.43619585417077	86.5554435144217	0.00330777942757254	13/4--166/2	0(0%)	0.00424109300845421	0.00330777942757254	0.000413980259777236	0.697416560069946	0.75
PCPG	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	30.446029765439	3.17236253133674	292.198864197088	0.00307121897561635	12/4--160/1	7(3.91%)	0.00119876746453218	0.00307121897561635	5.4477710898615e-05	0.718246288318629	0.846153846153846
PCPG	other_dx	Yes (vs No)	4.59904489383291	0.927067532089415	22.8151814224581	0.0618612126503666	27/3--152/3	0(0%)	0.0738943826288336	0.0618612126503666	0.04006388195643	0.111298854908301	0.59083850931677
PRAD	AR	(continuous)	0.731961455165509	0.237968681038298	2.25142052101295	0.586239249356371	351/7	149(29.8%)	0.589894776243655	0.586239249356371	0.586256323094144	0.190035170837027	0.821018062397373
PRAD	AR	H (vs L)	0.594924638434634	0.128397639684121	2.75655632212024	0.506800290443752	176/4--175/3	149(29.8%)	0.503663469171853	0.506800290443752	0.502625524777427	0.167729948626412	0.72495894909688
PRAD	gleason_pattern_primary	(continuous)	2.64439178378393	1.10445295039918	6.331467450575	0.0290364864476748	500/10	0(0%)	0.0299315512044952	0.0290364864476748	0.0218809091480414	0.0679120874725007	0.752434648898001
PRAD	gleason_pattern_secondary	(continuous)	2.76561849774348	1.02411660920054	7.4685300544356	0.0447518553117271	500/10	0(0%)	0.0314891552693989	0.0447518553117272	0.0346574157309486	0.677459127828823	0.694515633008713
PRAD	gleason_score	(continuous)	2.9956971952871	1.35380084758548	6.62889353471495	0.00678008221272819	500/10	0(0%)	0.00189586713735235	0.00678008221272819	0.00197171433654297	0.682126751637764	0.781906714505382
PRAD	psa_most_recent_results	(continuous)	1.06256013437945	1.004236578905	1.12427097647006	0.0351401695083794	443/10	57(11.4%)	9.31925677170042e-05	0.0351401695083793	0	0.762495618061166	0.661572052401747
PRAD	age_at_initial_pathologic_diagnosis	(continuous)	1.05275186796644	0.955320068288131	1.16012060491182	0.299509137759007	500/10	0(0%)	0.293642957192615	0.299509137759008	0.297329468910695	0.125605727218705	0.55407483341876
PRAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.69233888388513	1.34988517393464	24.0040579707556	0.0178569380359888	89/5--347/3	64(12.8%)	0.0165010135233825	0.0178569380359888	0.00760826944098647	0.308998033504921	0.705753823743627
PRAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	5.49470223421317	0.489099809474729	61.7292259326205	0.167437367644529	39/1--340/3	NA	NA	NA	NA	0.660694677100742	NA
PRAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	4.21753999703405	0.379643713432744	46.8535181729885	0.241368697249085	30/1--340/3	NA	NA	NA	NA	0.967335436843157	NA
PRAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	15.9534835589119	2.88307112416204	88.2786538047852	0.00150862755740078	29/4--340/3	NA	NA	NA	NA	0.802229070982415	NA
PRAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	62(12.4%)	0.0129517930327174	0.0168308107190206	0.000817044688143143	0.975020335978826	0.731821214142762
PRAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	8.90600580343629	1.79450749618729	44.1998373031943	0.00746504455395713	98/6--340/3	62(12.4%)	0.00321265169603757	0.00746504455395713	0.00120955742993545	0.748827287719332	0.698465643762508
PRAD	new_tumor_event_type	Biochemical_evidence_of_disease (vs NO)	0.871936282343177	0.101117204225287	7.5187292438641	0.900785609857172	70/1--409/6	NA	NA	NA	NA	0.295391895643525	NA
PRAD	new_tumor_event_type	Locoregional_Recurrence (vs NO)	5.40267144058401	0.588403561414336	49.6068695178208	0.135919814298095	8/1--409/6	NA	NA	NA	NA	0.576110275957334	NA
PRAD	new_tumor_event_type	New_Primary_Tumor (vs NO)	8.35964264444435e-08	0	Inf	0.998770193411503	7/0--409/6	NA	NA	NA	NA	0.99994771825683	NA
PRAD	new_tumor_event_type	Distant_Metastasis (vs NO)	21.3604820538731	3.80032786657036	120.060744649802	0.000509661978424392	6/2--409/6	NA	NA	NA	NA	0.653978495545124	NA
PRAD	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	0.0541742530227429	0.00860795045389728	2.2116413736617e-05	0.868201217872672	0.657355202460277
PRAD	new_tumor_event_dx_days_to	Yes (vs NO)	2.55665858412701	0.675117624129682	9.68202115033923	0.167065937478351	91/4--409/6	0(0%)	0.180648362936623	0.167065937478351	0.152595565039769	0.427871941719531	0.487442337262942
PRAD	radiation_therapy	YES (vs NO)	4.31023979302541	0.856412519319262	21.6930120173243	0.0763998303685441	40/2--460/8	0(0%)	0.120735560046562	0.0763998303685446	0.0533894601791853	0.877909854077413	0.554587391081497
PRAD	targeted_molecular_therapy	YES (vs NO)	2.60404155366673	0.533638606828207	12.7071623500547	0.236649746360828	43/2--457/8	0(0%)	0.280309310920346	0.236649746360828	0.219200268604318	0.673499250071299	0.640697078421322
PRAD	number_of_lymphnodes_positive_by_he	Yes (vs NO)	3.34590904166584	0.794399366597201	14.0925431034208	0.0997167680511717	80/3--420/7	0(0%)	0.125218441032033	0.0997167680511717	0.0806565042262199	0.975863353307999	0.60456176319836
PRAD	biochemical_recurrence_indicator	YES (vs NO)	7.35692742320784	1.97298206000221	27.4327791456384	0.00295903917358187	58/5--373/5	69(13.8%)	0.00425364011264429	0.00295903917358187	0.000486687477627368	0.765439517523973	0.681431005110733
READ	AR	(continuous)	0.456144304779844	0.0512563556700476	4.05935271954331	0.481562858347735	129/26	41(24.12%)	0.471912683180747	0.481562858347735	0.481592962997546	0.132356267157014	0.503639973527465
READ	AR	H (vs L)	0.458258660902102	0.207617593061522	1.01147979415001	0.053395640765702	65/16--64/10	41(24.12%)	0.0492842072767714	0.053395640765702	0.0476528398653228	0.537682534743804	0.57511581733951
READ	age_at_initial_pathologic_diagnosis	(continuous)	1.06921800107556	1.02560866068273	1.11468163018728	0.00163196553289502	170/26	0(0%)	0.000903082388187926	0.00163196553289502	0.00153762630791088	0.436418225977618	0.725736359246741
READ	gender	FEMALE (vs MALE)	1.22301155131703	0.565080081803346	2.64698279557381	0.609326121974865	78/13--92/13	0(0%)	0.609639834408177	0.609326121974865	0.608736859686705	0.938503336318585	0.52728150651859
READ	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.06789075476562	0.193776304325597	5.88508831398562	0.93987166354989	51/4--33/2	NA	NA	NA	NA	0.858453782948382	NA
READ	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.46043217455087	0.512669365460314	11.8082469783027	0.260559503237701	52/8--33/2	NA	NA	NA	NA	0.497068497345128	NA
READ	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	6.66325704776389	1.42844376927772	31.0820736801037	0.0157877706802825	25/9--33/2	NA	NA	NA	NA	0.168265219556585	NA
READ	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	9(5.29%)	0.00703651260473348	0.00630943860568511	0.00171883688007535	0.321185738910284	0.624854481955763
READ	pathologic_stage_v2	StageIII/IV (vs StageI/II)	3.55639867577698	1.39262909403971	9.08208193782545	0.00799394099608897	77/17--84/6	9(5.29%)	0.00435379713801909	0.00799394099608897	0.00473145937323227	0.179425744865114	0.60128055878929
READ	histological_type	Rectal_Mucinous_Adenocarcinoma (vs Rectal_Adenocarcinoma)	1.83000451796437	0.418134250648118	8.0091897054095	0.422367683404111	13/2--151/24	6(3.53%)	0.457359335047639	0.422367683404111	0.415332662843133	0.929857339738324	0.525360517155644
READ	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.98355446096162	2.52895206220606	19.284680654118	0.000176675002555249	55/15--103/5	12(7.06%)	3.75704664540288e-05	0.000176675002555249	1.35192030175091e-05	0.674758295317021	0.709637046307885
READ	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	10.0740978826402	0.83884318216853	120.98500685987	0.068546016825796	12/2--51/2	107(62.94%)	0.0609215748397326	0.068546016825796	0.0293727034323906	0.531927410400923	0.605263157894737
READ	residual_tumor	R1 (vs R0)	2.79714679922141	0.339847624830259	23.0221712460177	0.338854962920826	2/1--127/12	NA	NA	NA	NA	0.0395035457412219	NA
READ	residual_tumor	R2 (vs R0)	5.17823317035366	1.92203759948213	13.9508710827382	0.0011455361533419	12/6--127/12	NA	NA	NA	NA	0.361589476805009	NA
READ	residual_tumor	RX (vs R0)	1.94920531357814e-08	0	Inf	0.998195453774001	5/0--127/12	NA	NA	NA	NA	0.999923870648978	NA
READ	residual_tumor	Global	NA	NA	NA	NA	NA	24(14.12%)	0.0115672766961389	0.0132771570277198	0.00158822817074256	0.116004239889854	0.625
READ	new_tumor_event_dx_days_to	Yes (vs NO)	1.56014061917876	0.701685488290108	3.46884578950439	0.275280745926848	32/10--138/16	0(0%)	0.284782607543531	0.275280745926848	0.271558862229691	0.262288014019903	0.517865765330758
READ	number_of_lymphnodes_positive_by_he	Yes (vs NO)	3.43819903613186	1.48656737166623	7.95201942230723	0.00389278029406659	75/18--95/8	0(0%)	0.0024111336057322	0.00389278029406659	0.00217286596821487	0.194119708503727	0.601400289715114
READ	vascular_invasion_indicator	YES (vs NO)	1.69560483097639	0.734412933624271	3.9147945402353	0.216126285000692	38/8--132/18	0(0%)	0.233253373771409	0.216126285000693	0.210894043588297	0.708594320991248	0.570497344278126
READ	lymphovascular_invasion_indicator	YES (vs NO)	1.24926350932765	0.565171144513899	2.76139242225459	0.582363726424359	68/10--102/16	0(0%)	0.585855945780057	0.582363726424359	0.581599341712392	0.632838665937833	0.535007242877837
SARC	AR	(continuous)	0.936008454291396	0.748673713479239	1.17021849536228	0.561650114452688	221/84	40(15.33%)	0.556888905374266	0.561650114452688	0.561553330877394	0.477416400364457	0.502976454908929
SARC	AR	H (vs L)	0.89846989218499	0.585139849513952	1.37958156128565	0.624620607810962	111/41--110/43	40(15.33%)	0.624847137000086	0.624620607810962	0.624457508161179	0.932204890866746	0.512127943136384
SARC	age_at_initial_pathologic_diagnosis	(continuous)	1.02046999746196	1.00522358480849	1.03594765528547	0.00833197919251694	261/99	0(0%)	0.00721288121475216	0.00833197919251694	0.00834354466902654	0.954101806868353	0.582714360177222
SARC	gender	MALE (vs FEMALE)	0.831675940885317	0.557303543174131	1.24112771059731	0.36686385857641	119/41--142/58	0(0%)	0.36467184726703	0.36686385857641	0.366189945449274	0.717034923400462	0.528146989835809
SARC	histological_type	Dedifferentiated_liposarcoma (vs Leiomyosarcoma_(LMS))	1.24535039540951	0.761209951629402	2.03741110324012	0.382326911878961	59/26--105/41	NA	NA	NA	NA	0.968083255260856	NA
SARC	histological_type	Pleomorphic_'MFH'_/_Undifferentiated_pleomorphic_sarcoma (vs Leiomyosarcoma_(LMS))	1.06524188809954	0.547182221830521	2.07378864826009	0.852486152527077	29/11--105/41	NA	NA	NA	NA	0.381952751579389	NA
SARC	histological_type	Myxofibrosarcoma (vs Leiomyosarcoma_(LMS))	0.844042536887854	0.409966394764022	1.73772244060675	0.645379227257159	25/9--105/41	NA	NA	NA	NA	0.635852512360314	NA
SARC	histological_type	Undifferentiated_Pleomorphic_Sarcoma_(UPS) (vs Leiomyosarcoma_(LMS))	1.15263465497109	0.451552607500266	2.94221897022165	0.7663925783934	21/5--105/41	NA	NA	NA	NA	0.646769103837211	NA
SARC	histological_type	Malignant_Peripheral_Nerve_Sheath_Tumors_(MPNST) (vs Leiomyosarcoma_(LMS))	1.05030552189243	0.324869728101019	3.39564321910195	0.934662038856209	9/3--105/41	NA	NA	NA	NA	0.70569451260091	NA
SARC	histological_type	Synovial_Sarcoma_-_Monophasic (vs Leiomyosarcoma_(LMS))	1.14911421107176	0.355000667620656	3.71960841352021	0.816601054504203	6/3--105/41	NA	NA	NA	NA	0.193874527910499	NA
SARC	histological_type	Desmoid_Tumor (vs Leiomyosarcoma_(LMS))	6.75075059901524e-08	0	Inf	0.996616288724094	2/0--105/41	NA	NA	NA	NA	0.999843895684147	NA
SARC	histological_type	Sarcoma;_synovial;_poorly_differentiated (vs Leiomyosarcoma_(LMS))	4.69553021023874	0.632498546712402	34.8585843712459	0.130506824712656	2/1--105/41	NA	NA	NA	NA	0.976407143567554	NA
SARC	histological_type	Synovial_Sarcoma_-_Biphasic (vs Leiomyosarcoma_(LMS))	6.81899774161881e-08	0	Inf	0.99617895969953	2/0--105/41	NA	NA	NA	NA	0.999886706080294	NA
SARC	histological_type	Giant_cell_'MFH'_/_Undifferentiated_pleomorphic_sarcoma_with_giant_cells (vs Leiomyosarcoma_(LMS))	7.09241284514325e-08	0	Inf	0.999579806559979	1/0--105/41	NA	NA	NA	NA	0.999963475422353	NA
SARC	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.691746896519095	0.968993832257138	0.789767343374635	0.970239841503821	0.546716184519156
SARC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	8.86093229659328	4.82413346255296	16.2756942307435	2.027378265268e-12	123/81--129/12	9(3.45%)	0	2.027378265268e-12	0	0.0709661384629677	0.699491022197087
SARC	margin_status	Positive (vs Negative)	1.90664468900258	1.18441242332859	3.06928051285158	0.00789082067164559	74/31--137/38	50(19.16%)	0.00911927811484203	0.00789082067164559	0.0068883475235143	0.36358380338072	0.58961819467358
SARC	residual_tumor	R1 (vs R0)	2.21932674923493	1.42076983134058	3.46672002123123	0.000459525799228255	70/35--155/44	NA	NA	NA	NA	0.263077249846218	NA
SARC	residual_tumor	RX (vs R0)	2.2470752065767	1.18401080372805	4.2646122553215	0.0132621339959382	26/12--155/44	NA	NA	NA	NA	0.561242003228986	NA
SARC	residual_tumor	R2 (vs R0)	10.8781055401762	5.04214889591039	23.4687992334361	1.17372500607615e-09	9/8--155/44	NA	NA	NA	NA	0.368940250985482	NA
SARC	residual_tumor	Global	NA	NA	NA	NA	NA	1(0.38%)	5.08653239084111e-07	5.07563291396451e-09	7.21622761545859e-12	0.318222503030689	0.633507511430438
SARC	new_tumor_event_type	Distant_Metastasis (vs NO)	3.05886526083481	1.89743663970686	4.93120902597703	4.45847642793762e-06	68/41--136/29	NA	NA	NA	NA	0.0612488938614252	NA
SARC	new_tumor_event_type	Locoregional_Recurrence (vs NO)	2.3380218351796	1.39047671807358	3.93127481440313	0.00135875653594331	48/28--136/29	NA	NA	NA	NA	0.0974628812645144	NA
SARC	new_tumor_event_type	New_Primary_Tumor (vs NO)	0.501451664346312	0.0682962671818683	3.68180842162401	0.497401193504704	8/1--136/29	NA	NA	NA	NA	0.0676898798027009	NA
SARC	new_tumor_event_type	Locoregional_Disease (vs NO)	4.46329273227011e-07	0	Inf	0.994275657938372	1/0--136/29	NA	NA	NA	NA	0.999832384734601	NA
SARC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	0(0%)	1.21362072140752e-05	8.79078343567485e-05	1.60978339813767e-05	0.166836594751058	0.622230909564764
SARC	new_tumor_event_dx_days_to	Yes (vs NO)	2.40508950030182	1.55988631115253	3.70825454592787	7.1088285341081e-05	126/70--135/29	0(0%)	3.12416119144787e-05	7.1088285341081e-05	4.11281599296265e-05	0.0713894663883807	0.583984884023977
SARC	histologic_subtype	Poorly_differentiated_or_pleomorphic_or_epithelioid_leiomyosarcoma (vs Conventional_leiomyosarcoma)	1.86077868830543	0.997207842010328	3.47219223614549	0.0510357920388423	34/18--66/22	NA	NA	NA	NA	0.975974098953162	NA
SARC	histologic_subtype	Well-differentiated_leiomyosarcoma_(resembling_leiomyoma) (vs Conventional_leiomyosarcoma)	0.410920686091782	0.0544360472878383	3.10191166829751	0.388502478670765	4/1--66/22	NA	NA	NA	NA	0.275747787460666	NA
SARC	histologic_subtype	Global	NA	NA	NA	NA	NA	157(60.15%)	0.0675506599396921	0.0779894177039689	0.0659964840766801	0.548230152172355	0.582880434782609
SARC	tumor_total_depth	Superficial (vs Deep)	0.341539799535956	0.107580686345967	1.08429717850963	0.0683558340137109	21/3--187/74	53(20.31%)	0.0302795637639527	0.0683558340137109	0.0559619818526643	0.647016937830585	0.530055773600496
SARC	disease_multifocal_indicator	YES (vs NO)	2.38788013440648	1.49379115570963	3.81711426962118	0.000276085868488041	40/24--199/66	22(8.43%)	0.000734734490687949	0.000276085868488041	0.000175848927670863	0.917755947169756	0.574432130786764
SARC	locoregional_recurrence_indicator	YES (vs NO)	2.26922876629788	1.34496006251491	3.82866327210122	0.00213743122905519	29/21--144/43	88(33.72%)	0.00368862720273799	0.00213743122905519	0.00159730662010749	0.226125563372136	0.558269259761797
SARC	metastatic_disease_confirmed	YES (vs NO)	2.91491126673902	1.78261646824516	4.76642499624521	2.00810254217254e-05	56/37--121/28	84(32.18%)	1.95713116259988e-05	2.00810254217254e-05	7.87539223945366e-06	0.347769865804473	0.614813180347161
SKCM	AR	(continuous)	0.596913262156939	0.314797924268968	1.1318544852742	0.11397792999049	341/153	129(27.45%)	0.107853368088493	0.11397792999049	0.114432673367469	0.0693104927330352	0.568256194483403
SKCM	AR	H (vs L)	0.625647944458574	0.452322429293822	0.865390095769424	0.00460444141257854	170/81--171/72	129(27.45%)	0.00453867705169742	0.00460444141257854	0.00426967974663772	0.290634621182402	0.568918497740377
SKCM	breslow_thickness_at_diagnosis	(continuous)	1.02699733899341	1.01358446089112	1.04058771123252	7.13865078191267e-05	354/172	116(24.68%)	0.00121529953543575	7.13865078191267e-05	2.63649606140337e-05	0.659468427466256	0.676776628918431
SKCM	age_at_initial_pathologic_diagnosis	(continuous)	1.02524559678949	1.01574721501619	1.03483279914234	1.52019905330647e-07	455/214	15(3.19%)	7.22581183776327e-08	1.52019905330647e-07	1.21622068971483e-07	0.753116531715175	0.60621139679478
SKCM	race	ASIAN (vs WHITE)	4.42749698344487	2.04386539708426	9.59100808026708	0.000161627446489065	12/7--447/207	NA	NA	NA	NA	0.621528556081461	NA
SKCM	race	BLACK_OR_AFRICAN_AMERICAN (vs WHITE)	NA	NA	NA	NA	1/0--447/207	NA	NA	NA	NA	NA	NA
SKCM	race	Global	NA	NA	NA	NA	NA	25(5.32%)	0.00191154117814574	0.000161627446489065	3.64094222502498e-05	0.885270073717857	0.517704620705654
SKCM	gender	FEMALE (vs MALE)	0.84679281592007	0.634692663956336	1.1297721146233	0.258265317990245	180/71--290/145	15(3.19%)	0.253974666269766	0.258265317990245	0.25774456363484	0.0316513030531473	0.502175117476864
SKCM	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.60096746912369	1.1955187635658	2.14392020878662	0.00158574373605858	194/93--224/98	NA	NA	NA	NA	0.0526005997909216	NA
SKCM	pathologic_stage_v2	I/II_NOS (vs StageI/II)	0.407546871473167	0.147951135039504	1.12263047122428	0.0825256478497958	14/6--224/98	NA	NA	NA	NA	0.949925860645537	NA
SKCM	pathologic_stage_v2	Global	NA	NA	NA	NA	NA	51(10.85%)	0.000351869125045701	0.000752263987709556	0.000536061317673586	0.146993133770224	0.587850807921273
SKCM	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.125973542169875	0.0794109466126749	0.199838108015857	0	214/20--247/190	23(4.89%)	0	0	0	0.172944219856595	0.673387702543191
SKCM	new_tumor_event_dx_days_to	NO (vs Yes)	0.651538490020508	0.471918404537303	0.899525002408862	0.00922959678213675	190/49--280/167	15(3.19%)	0.00692563882894248	0.00922959678213675	0.00871687786871089	0.903859201245234	0.543389489668192
SKCM	clark_level_at_diagnosis	IV (vs V)	0.549304027550771	0.361445742929841	0.834800023477015	0.00502362086389718	168/90--52/30	NA	NA	NA	NA	0.564065786416111	NA
SKCM	clark_level_at_diagnosis	III (vs V)	0.314848548651524	0.190233128268039	0.521095402732889	6.93808522067574e-06	77/36--52/30	NA	NA	NA	NA	0.534194135629338	NA
SKCM	clark_level_at_diagnosis	II (vs V)	0.190110843682848	0.078410110409746	0.460937150795186	0.000238850350996467	18/6--52/30	NA	NA	NA	NA	0.140261829549175	NA
SKCM	clark_level_at_diagnosis	I (vs V)	3.79113058477545e-07	0	Inf	0.994441528399767	6/0--52/30	NA	NA	NA	NA	0.999638439957032	NA
SKCM	clark_level_at_diagnosis	Global	NA	NA	NA	NA	NA	156(33.19%)	1.34406024432376e-05	2.81351360614801e-05	8.97063435190137e-06	0.697822987416683	0.622511245843927
SKCM	primary_melanoma_tumor_ulceration	YES (vs NO)	2.36485507873518	1.76463614736578	3.16923097816397	8.30888957636944e-09	167/78--303/138	15(3.19%)	3.05680634138383e-08	8.30888957636944e-09	3.34001581947518e-09	0.431077008364562	0.598875505304414
SKCM	submitted_tumor_site.1	Regional_Lymph_Node (vs Primary_Tumor)	0.339106913483882	0.215866982483201	0.532705360726085	2.69299139588064e-06	222/107--103/30	NA	NA	NA	NA	0.523621034148686	NA
SKCM	submitted_tumor_site.1	Regional_Cutaneous_or_Subcutaneous_Tissue_(includes_satellite_and_in-transit_metastasis) (vs Primary_Tumor)	0.356031581115566	0.213213780233116	0.594513575121922	7.88772744394484e-05	74/40--103/30	NA	NA	NA	NA	0.608659289757585	NA
SKCM	submitted_tumor_site.1	Distant_Metastasis (vs Primary_Tumor)	0.335604212720684	0.197600088548607	0.569990572489871	5.34526628430676e-05	68/38--103/30	NA	NA	NA	NA	0.915184644762416	NA
SKCM	submitted_tumor_site.1	Global	NA	NA	NA	NA	NA	18(3.83%)	0.000179404911792469	3.42912305991705e-05	1.25746187323861e-05	0.492562212794322	0.557548812336774
STAD	AR	(continuous)	1.75878214854507	0.792756838945753	3.90197156817271	0.164909467392174	351/138	92(20.77%)	0.168654411714357	0.164909467392174	0.165250373694467	0.324104643424006	0.527646443137113
STAD	AR	H (vs L)	0.989721118987203	0.708247673138207	1.38305839965412	0.951744525169209	176/67--175/71	92(20.77%)	0.951747001760445	0.951744525169209	0.951744313806323	0.39900369215632	0.493377124914282
STAD	age_at_initial_pathologic_diagnosis	(continuous)	1.01682913447833	1.00233213592857	1.03153580700682	0.0227320235881517	434/169	9(2.03%)	0.021217824159628	0.0227320235881517	0.0226420999146736	0.588038385060373	0.540059207743997
STAD	gender	FEMALE (vs MALE)	0.931245732118599	0.677689424543992	1.27966968670442	0.660471928802968	158/58--285/114	6(1.35%)	0.659318029168762	0.660471928802968	0.660404963696021	0.513928186148286	0.503274348613627
STAD	ajcc_pathologic_tumor_stage	Stage_II (vs Stage_I)	1.45636962431969	0.756600632654334	2.80334484416179	0.260513122972546	130/37--59/13	NA	NA	NA	NA	0.75517502112594	NA
STAD	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_I)	2.58964427126557	1.41204166773078	4.74933396439774	0.00210493191228045	183/85--59/13	NA	NA	NA	NA	0.841953887578897	NA
STAD	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_I)	4.45200288126768	2.24443289886076	8.83088537192454	1.92434655804652e-05	44/26--59/13	NA	NA	NA	NA	0.152733712438861	NA
STAD	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	33(7.45%)	2.18851452538082e-06	3.16454811122302e-06	9.84876004528346e-07	0.248485387019251	0.622903449515835
STAD	pathologic_stage_v2	StageIII/IV (vs StageI/II)	2.19934111532054	1.56635922841664	3.08811749807163	5.3291451181936e-06	227/111--189/50	33(7.45%)	2.14456759695114e-06	5.3291451181936e-06	3.02146290720451e-06	0.699534050994939	0.595497392957131
STAD	histological_grade	G2 (vs G3)	0.768060866078091	0.554415043044841	1.06403587240492	0.11257073430919	159/56--263/109	NA	NA	NA	NA	0.0659190034471703	NA
STAD	histological_grade	G1 (vs G3)	0.642342034449709	0.203793835896165	2.0246112322613	0.449831861314257	12/3--263/109	NA	NA	NA	NA	0.498486441302495	NA
STAD	histological_grade	GX (vs G3)	1.27171409092702	0.468170200753358	3.45442047883424	0.637324250900643	9/4--263/109	NA	NA	NA	NA	0.739551424358488	NA
STAD	histological_grade	Global	NA	NA	NA	NA	NA	6(1.35%)	0.335278813236404	0.344561823315493	0.340585821024873	0.268765729840814	0.550845292833589
STAD	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	1.31519449485758	0.954717507389832	1.81177840137521	0.0936548972443635	263/109--171/59	NA	NA	NA	NA	0.0569181742694019	NA
STAD	histological_grade_v2	GX (vs G_1/2/Low)	1.67279079563284	0.606315210581929	4.61513911760235	0.320400917111458	9/4--171/59	NA	NA	NA	NA	0.353542385843349	NA
STAD	histological_grade_v2	Global	NA	NA	NA	NA	NA	6(1.35%)	0.192584135748402	0.196982202441498	0.194478556949188	0.140544697525029	0.550171845246389
STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Not_Otherwise_Specified_(NOS) (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.870702763185971	0.573213799899221	1.32258382815099	0.516250430248989	82/37--164/61	NA	NA	NA	NA	0.774623590348434	NA
STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Tubular_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.810897320092876	0.524501111118116	1.25367601668575	0.345708795375978	79/31--164/61	NA	NA	NA	NA	0.690042092845552	NA
STAD	histological_type	Stomach_Adenocarcinoma_Diffuse_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.816552946277001	0.519865730194466	1.2825594674691	0.379009828187511	72/28--164/61	NA	NA	NA	NA	0.214913464728138	NA
STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Mucinous_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.208706425190563	0.06534010419893	0.666640686449004	0.00818520471282991	22/3--164/61	NA	NA	NA	NA	0.500562336326375	NA
STAD	histological_type	Stomach_Adenocarcinoma_Signet_Ring_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	1.57583640490081	0.778631769230257	3.1892615651499	0.206107630762153	13/9--164/61	NA	NA	NA	NA	0.293855997859607	NA
STAD	histological_type	Stomach_Intestinal_Adenocarcinoma_Papillary_Type (vs Stomach_Adenocarcinoma_Not_Otherwise_Specified_(NOS))	0.693706139152211	0.217328259633195	2.21429191173609	0.536861046922085	8/3--164/61	NA	NA	NA	NA	0.786520674192133	NA
STAD	histological_type	Global	NA	NA	NA	NA	NA	9(2.03%)	0.0242791593901582	0.0980146392025398	0.0579597028644492	0.695229011380924	0.557310448180584
STAD	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	5.01886637126902	3.48063065148291	7.23691255259255	0	144/99--251/44	53(11.96%)	0	0	0	0.00328648462396908	0.665716333271016
STAD	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	3.04544284511786	1.10405760611773	8.40057807807042	0.0314617719300956	7/4--274/68	NA	NA	NA	NA	0.308308496849145	NA
STAD	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	2.47462038434078	1.13199573726148	5.40969002357682	0.0231672713798849	18/8--274/68	NA	NA	NA	NA	0.43549450092608	NA
STAD	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	4.64674698858486	3.22685593365061	6.69142286482393	1.11022302462516e-16	72/55--274/68	NA	NA	NA	NA	0.291211446746439	NA
STAD	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	76(17.16%)	1.29340982368831e-13	7.32747196252603e-15	0	0.549750577581787	0.652913518052057
STAD	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	4.12949515792887	2.91512371806162	5.84974495377404	1.4432899320127e-15	97/67--274/68	76(17.16%)	1.0769163338864e-14	1.4432899320127e-15	0	0.199920972571848	0.646532325776658
STAD	residual_tumor	R1 (vs R0)	1.64574081316342	0.8337863392025	3.24838954150098	0.151002091392732	18/9--350/119	NA	NA	NA	NA	0.339241227523391	NA
STAD	residual_tumor	R2 (vs R0)	7.7328638322848	4.37304810078093	13.6740281996852	2.01827443646607e-12	19/14--350/119	NA	NA	NA	NA	0.963738520019748	NA
STAD	residual_tumor	RX (vs R0)	6.62796612325966	3.69179701484765	11.8993364896284	2.38049469025725e-10	25/13--350/119	NA	NA	NA	NA	0.889514209667882	NA
STAD	residual_tumor	Global	NA	NA	NA	NA	NA	36(8.13%)	7.98527910461644e-12	0	0	0.808291804173342	0.60299927661232
STAD	new_tumor_event_dx_days_to	Yes (vs NO)	1.95049529644793	1.43547725865898	2.6502906113745	1.94625035201401e-05	115/75--328/97	6(1.35%)	2.9564971641971e-05	1.94625035201401e-05	1.3643478791403e-05	4.37239110584464e-07	0.537933677023826
STAD	radiation_therapy	YES (vs NO)	0.527007913912873	0.320814293267614	0.865726207202113	0.0114284527135629	51/20--392/152	6(1.35%)	0.00620890106053285	0.0114284527135629	0.0101904031530722	0.543660576290575	0.535715944452185
STAD	targeted_molecular_therapy	YES (vs NO)	0.659782584961185	0.455746829386537	0.955164208172379	0.0275965125006187	102/38--341/134	6(1.35%)	0.0222197196781301	0.0275965125006187	0.0265229954164894	0.208693618393703	0.545666713111328
STAD	number_of_lymphnodes_positive_by_he	NO (vs Yes)	0.621359561619286	0.442643215430105	0.872232288572546	0.00596013434796594	165/48--278/124	6(1.35%)	0.00449714036199222	0.00596013434796594	0.00550667292726892	0.843351919909919	0.549301007849148
STAD	history_reflux_disease_indicator	YES (vs NO)	0.573720048967135	0.311281090347635	1.05741949894629	0.0749127353356543	46/11--397/161	6(1.35%)	0.0532774023451169	0.0749127353356542	0.0712352650391957	0.866596668703529	0.52271143932005
TGCT	AR	(continuous)	0.316849710604621	0.0528594341991071	1.89925867787529	0.208427018276988	104/4	30(22.39%)	0.219018132750523	0.208427018276988	0.224675673603887	0.992676760722059	0.694029850746269
TGCT	AR	H (vs L)	2.05010981387872e-09	0	Inf	0.998733793586099	52/4--52/0	30(22.39%)	0.0346313033613463	0.998733793586099	0.0823341044576723	0.999982022498332	0.740671641791045
TGCT	age_at_initial_pathologic_diagnosis	(continuous)	0.8902094517348	0.763806551911916	1.03753085905626	0.136638554358481	134/4	0(0%)	0.102063906666746	0.136638554358481	0.141001396753879	0.84336974863722	0.698275862068966
TGCT	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	27545521224.8394	0	Inf	0.999043016410777	7/3--126/1	1(0.75%)	1.47549048138407e-05	0.999043016410777	1.99840144432528e-15	0.999989561370688	0.976811594202899
TGCT	new_tumor_event_type	Yes (vs NO)	2.73099185542635	0.383944216638909	19.425521185593	0.315541678427207	33/2--101/2	0(0%)	0.325220335842282	0.315541678427207	0.295476598027669	0.928491471090276	0.673850574712644
TGCT	postoperative_rx_tx	YES (vs NO)	0.562514978503494	0.057072630890677	5.54421788697452	0.622132742336724	42/1--92/3	0(0%)	0.607379442808186	0.622132742336724	0.617637678810038	0.17159709540528	0.65948275862069
TGCT	history_of_undescended_testis	Yes (vs No)	1.25402541219027	0.129734463131838	12.121526512357	0.844953618215112	23/1--111/3	0(0%)	0.847875295503197	0.844953618215112	0.844629796261783	0.737227951841156	0.550287356321839
TGCT	lymphovascular_invasion_present	YES (vs NO)	3.15813939310638	0.312525473133704	31.9137007498372	0.329839268088738	55/3--79/1	0(0%)	0.298330607656854	0.329839268088738	0.306653738818626	0.812560530791332	0.627873563218391
THCA	AR	(continuous)	2.237703641267	0.605967095891947	8.26334898393965	0.226886368508001	372/16	135(26.63%)	0.260018629099081	0.226886368508001	0.226515170570417	0.195350107036958	0.536171685704396
THCA	AR	H (vs L)	2.78926588557354	0.963900401123827	8.07137767693998	0.0584718929596501	186/5--186/11	135(26.63%)	0.0480114754405249	0.0584718929596501	0.0484458402975951	0.804100463369259	0.600207684319834
THCA	tumor_size_width	(continuous)	1.34544281304191	1.04453369643612	1.73303778455638	0.0216018340903017	478/15	29(5.72%)	0.0322876581129996	0.0216018340903017	0.0209656811439232	0.327818554914528	0.651162790697674
THCA	tumor_size_width.1	(continuous)	1.58235585535712	1.05401805203976	2.37552862414211	0.0268462698358696	429/12	78(15.38%)	0.0392283328605725	0.0268462698358696	0.0264887299114364	0.242476255047138	0.648840992273282
THCA	tumor_size_width.2	(continuous)	1.86457392052246	1.06061850698934	3.27793252916283	0.030432375063406	407/12	100(19.72%)	0.0406376271682507	0.030432375063406	0.0275796941312485	0.307225312585722	0.637320977253581
THCA	age_at_initial_pathologic_diagnosis	(continuous)	1.12045685841024	1.07857333471031	1.16396681723616	4.87702478402241e-09	507/16	0(0%)	3.39850370068007e-12	4.87702478402241e-09	4.28768132110235e-13	0.801849742422501	0.92902711323764
THCA	gender	MALE (vs FEMALE)	1.99813274233391	0.722849698248348	5.5233258942513	0.182092521616774	136/6--371/10	0(0%)	0.1981269798536	0.182092521616774	0.173637739507055	0.685725644214053	0.569510898458267
THCA	pathologic_stage_v2	StageIII/IV (vs StageI/II)	7.21118096079512	2.32054800084127	22.4089873730179	0.00063752750696433	168/12--337/4	2(0.39%)	0.000171883957182817	0.00063752750696433	6.61540824322682e-05	0.33443368384294	0.735584623598505
THCA	histological_type	Thyroid_Papillary_Carcinoma_-_Follicular_(>=_99%_follicular_patterned) (vs Thyroid_Papillary_Carcinoma_-_Classical/usual)	0.290217901141884	0.0382674995759707	2.20099120863618	0.231391629017586	102/1--359/15	NA	NA	NA	NA	0.702432776120167	NA
THCA	histological_type	Thyroid_Papillary_Carcinoma_-_Tall_Cell_(>=_50%_tall_cell_features) (vs Thyroid_Papillary_Carcinoma_-_Classical/usual)	2.97376983556581e-08	0	Inf	0.997393575828145	37/0--359/15	NA	NA	NA	NA	0.999958603424588	NA
THCA	histological_type	Other,_specify (vs Thyroid_Papillary_Carcinoma_-_Classical/usual)	2.95635555655927e-08	0	Inf	0.998762501517747	9/0--359/15	NA	NA	NA	NA	0.999975218096016	NA
THCA	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.212922545466308	0.697981310747577	0.389075087053884	0.98580276407091	0.60672514619883
THCA	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	25.0136807280652	6.46491944568568	96.7814415666272	3.10779500212188e-06	44/7--451/3	12(2.37%)	1.83332442016404e-06	3.10779500212188e-06	3.6418645876779e-12	0.38241189376264	0.864006514657981
THCA	residual_tumor	R1 (vs R0)	4.15194015436151	1.24967389767319	13.794484367079	0.0201368165845037	52/4--389/8	NA	NA	NA	NA	0.551208378064432	NA
THCA	residual_tumor	RX (vs R0)	6.36933380982079	1.68015442777439	24.1456454896619	0.00646673003792719	30/3--389/8	NA	NA	NA	NA	0.564450904463909	NA
THCA	residual_tumor	R2 (vs R0)	1.78069578341721e-07	0	Inf	0.997554157439702	4/0--389/8	NA	NA	NA	NA	0.999878395063789	NA
THCA	residual_tumor	Global	NA	NA	NA	NA	NA	32(6.31%)	0.0263658384318115	0.0193670969909092	0.0046130467992771	0.805570492349057	0.707810539523212
THCA	other_dx	Yes (vs No)	5.28765680104101	1.70195918456229	16.4277232375498	0.00398430920435888	34/4--473/12	0(0%)	0.0138088992726713	0.00398430920435888	0.0012695653708239	0.18096003043909	0.634370015948963
THCA	number_of_lymphnodes_positive_by_he	Yes (vs NO)	0.72423592255307	0.262755937571435	1.99621624677348	0.532827972126306	219/6--288/10	0(0%)	0.528163434373561	0.532827972126306	0.531068461067413	0.0950356606206568	0.574561403508772
THCA	history_thyroid_disease	Nodular_Hyperplasia (vs Normal)	0.535221670775612	0.0685316070175982	4.18000174422113	0.551138482320838	69/1--281/14	NA	NA	NA	NA	0.646227166398333	NA
THCA	history_thyroid_disease	Lymphocytic_Thyroiditis (vs Normal)	9.95747277683354e-09	0	Inf	0.998204587989114	43/0--281/14	NA	NA	NA	NA	0.999984317587391	NA
THCA	history_thyroid_disease	Other,_specify (vs Normal)	9.85010513180174e-09	0	Inf	0.998491787471563	26/0--281/14	NA	NA	NA	NA	0.99998185271135	NA
THCA	history_thyroid_disease	Lymphocytic_Thyroiditis|Nodular_Hyperplasia (vs Normal)	9.36881073331273e-09	0	Inf	0.99879601095834	23/0--281/14	NA	NA	NA	NA	0.999958032937034	NA
THCA	history_thyroid_disease	Lymphocytic_Thyroiditis|Other,_specify (vs Normal)	1.00858545600573e-08	0	Inf	0.999163211616163	5/0--281/14	NA	NA	NA	NA	0.999999774644766	NA
THCA	history_thyroid_disease	Lymphocytic_Thyroiditis|Nodular_Hyperplasia|Other,_specify (vs Normal)	1.0366294173749e-08	0	Inf	0.999531074216846	1/0--281/14	NA	NA	NA	NA	0.999993142845188	NA
THCA	history_thyroid_disease	Normal|Other,_specify (vs Normal)	9.12079381173658e-09	0	Inf	0.999833019681745	1/0--281/14	NA	NA	NA	NA	0.999991035800231	NA
THCA	history_thyroid_disease	Global	NA	NA	NA	NA	NA	58(11.44%)	0.467834404332683	0.99982298133918	0.787892209803136	0.999969939484269	0.614644970414201
THCA	tumor_focality	Multifocal (vs Unifocal)	0.255844065968498	0.0577508151301166	1.13342445372963	0.0726467823024999	228/2--269/14	10(1.97%)	0.0359464992367424	0.0726467823025	0.0532578321516186	0.274839515528401	0.628301886792453
THCA	extrathyroidal_extension	Minimal_(T3) (vs None)	1.1551822251726	0.336215863451369	3.96901549991184	0.8188089988854	134/4--354/7	NA	NA	NA	NA	0.407559345521603	NA
THCA	extrathyroidal_extension	Moderate/Advanced_(T4a) (vs None)	8.36589731792354	2.43495926976192	28.7430836331334	0.000743070747986518	18/4--354/7	NA	NA	NA	NA	0.861442058285909	NA
THCA	extrathyroidal_extension	Very_Advanced_(T4b) (vs None)	NA	NA	NA	NA	1/1--354/7	NA	NA	NA	NA	NA	NA
THCA	extrathyroidal_extension	Global	NA	NA	NA	NA	NA	0(0%)	2.73782135046252e-05	0.00191571636713816	0	0.814452431469346	0.710393407761829
THYM	AR	(continuous)	0.4571073473311	0.135009438688335	1.54764829047562	0.208359489248104	89/8	35(28.23%)	0.222692407755589	0.208359489248104	0.202062974397776	0.789150390927447	0.62287104622871
THYM	AR	H (vs L)	0.137172672287545	0.016761709864524	1.12257891197192	0.064003433401421	44/7--45/1	35(28.23%)	0.0220392412103304	0.064003433401421	0.0305524296180294	0.376869376810527	0.647201946472019
THYM	age_at_initial_pathologic_diagnosis	(continuous)	1.05438715397318	0.995307915001427	1.11697320367645	0.0718441671082733	123/9	1(0.81%)	0.0521471869049084	0.0718441671082735	0.060890268692342	0.724112110761843	0.718697829716194
THYM	gender	FEMALE (vs MALE)	1.55270263522246	0.415261284140501	5.80570731128179	0.513183067869144	60/5--64/4	1(0.81%)	0.511438218773067	0.513183067869144	0.509844432227667	0.321473917774753	0.519198664440735
THYM	clinical_stage_v2	StageIII/IV (vs StageI/II)	1.52920506281469	0.313236329588776	7.46550736055449	0.599548320431318	23/2--99/7	3(2.42%)	0.613720383853392	0.599548320431318	0.596858017873869	0.454283948684764	0.578947368421053
THYM	histological_type	Type_AB (vs Type_A)	0.278104140090177	0.0251139290470391	3.07964208190733	0.296887984564358	38/1--17/2	NA	NA	NA	NA	0.405247648733171	NA
THYM	histological_type	Type_B (vs Type_A)	0.411460761784225	0.071902383660745	2.35458061149764	0.318386628817343	58/4--17/2	NA	NA	NA	NA	0.853238577330712	NA
THYM	histological_type	Type_C (vs Type_A)	1.50765358526284	0.204720251619526	11.1030507005254	0.686942353893243	11/2--17/2	NA	NA	NA	NA	0.30800710482936	NA
THYM	histological_type	Global	NA	NA	NA	NA	NA	1(0.81%)	0.38763546940829	0.347006279297964	0.285558775839391	0.633437373223073	0.656928213689483
THYM	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	6.72761256901801	1.74823460074744	25.8894148757028	0.00556447975147278	10/4--113/5	2(1.61%)	0.01104244680571	0.00556447975147278	0.00158001179537082	0.695463177218104	0.640939597315436
THYM	new_tumor_event_type	Yes (vs NO)	4.5204173769458	1.18879293414533	17.1890096877842	0.0268470215112084	21/5--103/4	1(0.81%)	0.02942774197061	0.0268470215112084	0.0159866546240748	0.167678950899148	0.574290484140234
UCEC	AR	(continuous)	0.992022837076829	0.705592858045533	1.39472685708286	0.963251553722967	403/72	145(26.46%)	0.963240977395141	0.963251553722967	0.96325148173728	0.0393063820673457	0.553990610328638
UCEC	AR	H (vs L)	0.685630832580149	0.428865316290634	1.09612416935572	0.114894177529692	201/42--202/30	145(26.46%)	0.112163101798156	0.114894177529692	0.112769910747521	0.0312264389395097	0.573668347533762
UCEC	BMI	(continuous)	0.991430312346075	0.969523083139715	1.01383255471906	0.450285019077563	516/87	32(5.84%)	0.429562166220111	0.450285019077563	0.45895212752493	0.957969148473551	0.518278125932557
UCEC	tumor_invasion_percent	(continuous)	1.0123399785977	1.0083735904021	1.01632196838726	9.17378062403884e-10	474/79	74(13.5%)	8.46843584811907e-07	9.17378062403884e-10	4.99988284108355e-09	0.716667328856223	0.702613813397957
UCEC	age_at_initial_pathologic_diagnosis	(continuous)	1.03466170681358	1.01479824986767	1.05491396707275	0.000570563184027262	545/91	3(0.55%)	0.000537554418343356	0.000570563184027262	0.000571527385641479	0.929749146796941	0.599836668027766
UCEC	clinical_stage_v2	StageIII/IV (vs StageI/II)	3.96880377133851	2.61840474027153	6.01564881591125	8.2406970136617e-11	154/50--394/41	1(0.18%)	1.50027101852857e-10	8.2406970136617e-11	2.43038922320693e-12	0.00888103136218377	0.690273442800923
UCEC	histological_grade_v2	G_3/4/High (vs G_1/2/Low)	3.44859027814175	2.00885973561001	5.92016191856342	7.12357734056202e-06	327/75--221/16	1(0.18%)	4.53439546355128e-07	7.12357734056202e-06	1.7547840726051e-06	0.335685360967483	0.629902293391233
UCEC	histological_type	Serous_endometrial_adenocarcinoma (vs Endometrioid_endometrial_adenocarcinoma)	2.91029074492359	1.88827410432485	4.48546754975294	1.29834599504886e-06	115/36--411/49	NA	NA	NA	NA	0.371237854766959	NA
UCEC	histological_type	Mixed_serous_and_endometrioid (vs Endometrioid_endometrial_adenocarcinoma)	2.90786223831668	1.2418156318653	6.80911286672008	0.0139380890794647	22/6--411/49	NA	NA	NA	NA	0.224618063400281	NA
UCEC	histological_type	Global	NA	NA	NA	NA	NA	1(0.18%)	6.68587280672206e-06	2.87497117901214e-06	8.39970334509665e-07	0.388064149878561	0.602761568733885
UCEC	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	11.3535757825846	7.24755354926745	17.7858200252857	0	101/60--427/29	21(3.83%)	0	0	0	0.799714187514814	0.763543089260076
UCEC	treatment_outcome_first_course	Partial_Remission/Response (vs Complete_Remission/Response)	7.11569036881143	3.01938291951941	16.7693369057194	7.24064329615803e-06	12/6--441/53	NA	NA	NA	NA	0.73409846204691	NA
UCEC	treatment_outcome_first_course	Stable_Disease (vs Complete_Remission/Response)	5.24378199036264	1.62699960725491	16.9005877074827	0.00551803790054572	6/3--441/53	NA	NA	NA	NA	0.982366506744517	NA
UCEC	treatment_outcome_first_course	Progressive_Disease (vs Complete_Remission/Response)	9.00677801482515	4.8658487375934	16.671716402031	2.6256774532385e-12	20/13--441/53	NA	NA	NA	NA	0.107717327637998	NA
UCEC	treatment_outcome_first_course	Global	NA	NA	NA	NA	NA	69(12.59%)	6.82187306644266e-10	8.09352584951739e-14	0	0.453043486193027	0.656988995551393
UCEC	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	7.70160656244223	4.63380601403511	12.8004373646626	3.44169137633799e-15	38/22--441/53	69(12.59%)	2.20331530798035e-11	3.44169137633799e-15	0	0.197915238793586	0.654273003980333
UCEC	residual_tumor	RX (vs R0)	1.95994161067631	0.99090732699209	3.87661995488615	0.0531481308482469	41/10--376/51	NA	NA	NA	NA	0.292687482169113	NA
UCEC	residual_tumor	R1 (vs R0)	1.72064491952832	0.684383916288008	4.32596218092989	0.248608081291893	22/5--376/51	NA	NA	NA	NA	0.818914821672982	NA
UCEC	residual_tumor	R2 (vs R0)	6.05863601475935	3.14169977787225	11.6838249847665	7.59565469410362e-08	16/11--376/51	NA	NA	NA	NA	0.640269368200988	NA
UCEC	residual_tumor	Global	NA	NA	NA	NA	NA	94(17.15%)	6.49651543697116e-05	1.33557235992843e-06	3.55430831433523e-08	0.665677492707617	0.595771506158472
UCEC	new_tumor_event_type	Metastatic (vs NO)	3.33456028847627	1.74259004931496	6.38089969689319	0.000275556608143601	27/11--463/54	NA	NA	NA	NA	0.733351923989271	NA
UCEC	new_tumor_event_type	Locoregional_Recurrence (vs NO)	4.22278292721573	2.29599454925077	7.76652351208917	3.59550269712905e-06	25/13--463/54	NA	NA	NA	NA	0.00282685338312083	NA
UCEC	new_tumor_event_type	Locoregional_Disease (vs NO)	2.78289111048004	0.999596307596804	7.74761058432464	0.0500904145070851	12/4--463/54	NA	NA	NA	NA	0.571636010367834	NA
UCEC	new_tumor_event_type	New_Primary_Tumor (vs NO)	1.62431046915911	0.506988107379487	5.20403627189032	0.414188056774652	11/3--463/54	NA	NA	NA	NA	0.331788430682451	NA
UCEC	new_tumor_event_type	Distant_Metastasis (vs NO)	6.76672590059774	2.8900527218037	15.8435100745302	1.05804549492827e-05	10/6--463/54	NA	NA	NA	NA	0.503429351614484	NA
UCEC	new_tumor_event_type	Global	NA	NA	NA	NA	NA	1(0.18%)	1.33673854407768e-06	4.03230129286669e-08	6.52574771997649e-10	0.0498005792698352	0.605628307775818
UCEC	new_tumor_event_dx_days_to	Yes (vs NO)	4.67860981627939	3.09350757041726	7.07591279953885	2.665645482125e-13	109/50--439/41	1(0.18%)	8.3322237998118e-13	2.665645482125e-13	7.7715611723761e-16	0.136697263969949	0.648408875016963
UCEC	peritoneal_washing	positive (vs negative)	4.65163018365563	2.83978596960567	7.61946977592142	1.02617259134519e-09	58/25--353/46	137(25%)	3.38455294901507e-08	1.02617259134519e-09	1.88430382408455e-11	0.965006789935215	0.63328705310656
UCEC	lymph_nodes_pelvic_pos_by_he	Yes (vs NO)	4.01019851122616	2.46018845370546	6.53677244733781	2.53068067612716e-08	56/22--492/69	1(0.18%)	8.68736661385761e-07	2.53068067612716e-08	1.70690073186819e-09	0.248123583897359	0.607833491654227
UCEC	lymph_nodes_pelvic_pos_total	Yes (vs NO)	3.65355147619352	2.31116575814866	5.77563004389978	2.93202885304211e-08	74/27--474/64	1(0.18%)	4.96661365367856e-07	2.93202885304211e-08	2.91317692191484e-09	0.252951724854568	0.619487040303976
UCEC	lymph_nodes_aortic_pos_by_he	Yes (vs NO)	2.45854820178412	1.2308435806056	4.91082648984685	0.0108235296860492	29/9--519/82	1(0.18%)	0.0231839255977502	0.0108235296860492	0.00841383085363734	0.762410310302639	0.534061609444972
UCEC	lymph_nodes_aortic_pos_total	Yes (vs NO)	2.96759712324405	1.64259681005446	5.36140861347125	0.000312780420979153	38/13--510/78	1(0.18%)	0.00149275617904643	0.000312780420979153	0.000154112943507756	0.769609060093154	0.552839598317275
UCS	AR	(continuous)	1.10900200813105	0.515228718096093	2.38706696820678	0.791382705346107	48/31	9(15.79%)	0.79231713194258	0.791382705346107	0.791379089648991	0.948552301170902	0.500583430571762
UCS	AR	H (vs L)	0.98540512896566	0.484338907710782	2.00484258591025	0.967637971624765	24/17--24/14	9(15.79%)	0.96763053173843	0.967637971624765	0.96763768725036	0.538370326633993	0.487747957992999
UCS	tumor_invasion_percent	(continuous)	1.02544978386753	1.01024349947703	1.04088495474439	0.000977346584219219	45/27	12(21.05%)	0.000545704927052082	0.000977346584219219	0.000551720196712124	0.359108452810743	0.690611664295875
UCS	age_at_initial_pathologic_diagnosis	(continuous)	1.0397266393255	0.999343346406329	1.0817418141728	0.053921713955019	57/35	0(0%)	0.0581079126284267	0.0539217139550191	0.0525932510036967	0.445076287585992	0.600353669319187
UCS	clinical_stage_v2	StageIII/IV (vs StageI/II)	2.48085142353254	1.20301251511582	5.11600977405531	0.0138752425207697	30/23--27/12	0(0%)	0.0106449758859504	0.0138752425207697	0.0110168136812036	0.816627351102418	0.613174182139699
UCS	histological_type	Uterine_Carcinosarcoma/_MMMT_Heterologous_Type (vs Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT)_NOS)	2.05970038442055	0.993290758217211	4.27102098603685	0.0521525707659886	20/16--24/14	NA	NA	NA	NA	0.968205758856076	NA
UCS	histological_type	Uterine_Carcinosarcoma/MMMT_Homologous_Type (vs Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT)_NOS)	0.534674575894833	0.191091685710601	1.4960195732496	0.2330049306192	13/5--24/14	NA	NA	NA	NA	0.305027986723192	NA
UCS	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.0157912759634842	0.0186097201111229	0.0128750359513776	0.553455716910554	0.653404067197171
UCS	tumor_status	TUMOR_FREE (vs WITH_TUMOR)	0.101402512381948	0.0241700732642184	0.425421528721362	0.00175921526629441	17/2--37/31	3(5.26%)	1.37671947746387e-05	0.00175921526629441	0.000124909351964297	0.828679315611152	0.656767283349562
UCS	treatment_outcome_first_course_v2	Uncomplete_Remission/Response (vs Complete_Remission/Response)	7.03639008873177	2.99782316081095	16.5155790801914	7.39490322998471e-06	18/16--31/12	8(14.04%)	4.57277342480467e-06	7.39490322998471e-06	3.56641579268846e-07	0.207455467674856	0.741792929292929
UCS	new_tumor_event_type	NO (vs Yes)	0.383859249324583	0.177695355469972	0.829216514423373	0.0148291221257696	26/10--31/25	0(0%)	0.00975790980573732	0.0148291221257696	0.0115866384854832	0.055032311274289	0.574270557029178
UCS	radiation_therapy	YES (vs NO)	0.471005243215152	0.235643472473925	0.941447419727332	0.0331121020284068	25/14--32/21	0(0%)	0.0307014754465564	0.0331121020284068	0.0296107899850595	0.216539724682499	0.616268788682582
UCS	postoperative_rx_tx	NO (vs YES)	2.05961806714708	1.04119211728582	4.07420159266744	0.0378990925301886	21/15--36/20	0(0%)	0.0432180654161319	0.0378990925301889	0.0342793486837164	0.028371389454085	0.622015915119363
UCS	lymph_nodes_pelvic_pos_by_he	Yes (vs NO)	0.92371362592501	0.415969962582897	2.05122229841173	0.845431689465878	13/8--44/27	0(0%)	0.844408891785501	0.845431689465878	0.845391997468809	0.488217427965856	0.519009725906278
UCS	lymph_nodes_aortic_pos_by_he	Yes (vs NO)	1.98176118568597	0.886487603051185	4.43026770320744	0.0956307512486372	9/8--48/27	0(0%)	0.11666036520659	0.0956307512486372	0.0893866280038141	0.203284913519098	0.534040671971706
UVM	AR	(continuous)	6.93890964830086	0.0067643164372642	7118.00927023991	0.583957453639959	12/2	68(85%)	0.557936903508886	0.583957453639959	0.577358510486017	0.862408107664382	0.619047619047619
UVM	AR	H (vs L)	1785501470.1376	0	Inf	0.999403361393964	6/0--6/2	68(85%)	0.0851787320313574	0.999403361393964	0.138457344821554	0.999997453880622	0.785714285714286
UVM	tumor_basal_diameter	(continuous)	1.16718120266467	1.01144096009373	1.34690210660195	0.0343746469541644	79/22	1(1.25%)	0.0326689316055325	0.0343746469541644	0.0339750981985868	0.902485558895476	0.611111111111111
UVM	tumor_thickness	(continuous)	1.11761300253648	0.94871075108781	1.31658550512516	0.183472643648566	80/23	0(0%)	0.174650022982276	0.183472643648566	0.180727709842926	0.768340728689173	0.600591715976331
UVM	BMI	(continuous)	1.05740548275087	1.00537578769503	1.11212779205179	0.0301416713110345	53/17	27(33.75%)	0.0598085484439586	0.0301416713110345	0.0267258680544342	0.681329164753571	0.564981949458484
UVM	age_at_initial_pathologic_diagnosis	(continuous)	1.04572380833438	1.00751561707901	1.08538097552051	0.0185611466148407	80/23	0(0%)	0.0133398190379863	0.0185611466148407	0.0167725473968693	0.172377177900154	0.682445759368836
UVM	gender	FEMALE (vs MALE)	0.648562648654511	0.273818345686756	1.53617723522059	0.32502377749995	35/8--45/15	0(0%)	0.316189946158188	0.32502377749995	0.321360491735415	0.511759459103131	0.571992110453649
UVM	ajcc_pathologic_tumor_stage	Stage_III (vs Stage_II)	1.18044518224451	0.473955236629776	2.94004733061477	0.721611180927267	36/11--39/8	NA	NA	NA	NA	0.47801146963616	NA
UVM	ajcc_pathologic_tumor_stage	Stage_IV (vs Stage_II)	69.9454918619946	6.77752890827936	721.851857516961	0.000361314006587454	4/3--39/8	NA	NA	NA	NA	0.957535826168388	NA
UVM	ajcc_pathologic_tumor_stage	Global	NA	NA	NA	NA	NA	1(1.25%)	0.000815168533404131	0.00157961146088326	2.07995731749122e-10	0.76032682497829	0.626782077393075
UVM	pathologic_stage_v2	StageIII/IV (vs StageI/II)	1.5018808811659	0.629197357572443	3.58495812810521	0.359542145292805	40/14--39/8	1(1.25%)	0.352217153417937	0.359542145292805	0.356264578316766	0.193425235280056	0.578411405295316
UVM	clinical_stage	Stage_III (vs Stage_II)	1.39960601763441	0.555751836751022	3.52476928560482	0.475592702633568	40/13--36/7	NA	NA	NA	NA	0.94902295702818	NA
UVM	clinical_stage	Stage_IV (vs Stage_II)	79.3422693422297	7.54571298062695	834.274470886631	0.000268938729875545	4/3--36/7	NA	NA	NA	NA	0.838648695212782	NA
UVM	clinical_stage	Global	NA	NA	NA	NA	NA	0(0%)	0.000640908979369192	0.00128505867021012	1.24150800751011e-10	0.979388488203819	0.618343195266272
UVM	clinical_stage_v2	StageIII/IV (vs StageI/II)	1.71846308027101	0.704268628796517	4.19316612654027	0.234190369944755	44/16--36/7	0(0%)	0.2202792063135	0.234190369944755	0.228648968904311	0.64250276020829	0.567061143984221
UVM	histological_type	Epithelioid_Cell (vs Spindle_Cell)	9.3345802013871	2.21001495026937	39.4270579597245	0.00237554022897457	13/6--30/3	NA	NA	NA	NA	0.647866681860314	NA
UVM	histological_type	Epithelioid_Cell|Spindle_Cell (vs Spindle_Cell)	4.08388240760512	1.16814675230905	14.2773974983702	0.027570901639634	37/14--30/3	NA	NA	NA	NA	0.603994526952921	NA
UVM	histological_type	Global	NA	NA	NA	NA	NA	0(0%)	0.00339582312526576	0.00987905753735152	0.00319216102139275	0.867839349547913	0.69181459566075
UVM	tumor_status	WITH_TUMOR (vs TUMOR_FREE)	10.759032420169	3.6498437144582	31.7155439175922	1.65314253437465e-05	25/19--55/4	0(0%)	2.73767654435098e-07	1.65314253437465e-05	7.85597739083599e-08	0.812712588345745	0.760848126232742
UVM	new_tumor_event_type	Yes (vs NO)	1.80341449048492	0.784440585216202	4.14601677397224	0.165030280836465	22/11--58/12	0(0%)	0.16983421521518	0.165030280836466	0.159583176957684	0.184824106788521	0.606508875739645
